arginine has been researched along with Brain Neoplasms in 178 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 63 (35.39) | 18.7374 |
| 1990's | 34 (19.10) | 18.2507 |
| 2000's | 28 (15.73) | 29.6817 |
| 2010's | 44 (24.72) | 24.3611 |
| 2020's | 9 (5.06) | 2.80 |
| Authors | Studies |
|---|---|
| Bishop, E; Dandapani, M; Dimitrova, M; Estevez-Cebrero, M; Froggatt, A; Grundy, RG; Mussai, F; Paine, S; Storer, LCD | 1 |
| Abrahantes-Pérez, MDC; Barajas-Olmos, F; García-Ortiz, H; Hernández-Cuenca, YE; Jiménez-Morales, JM; Orozco, L; Quiñones-Hinojosa, A; Reyes-Abrahantes, A; Reyes-González, J; Ruiz-García, H | 1 |
| Coll-Font, J; Farrar, CT; Foster, AN; Gerstner, ER; Herz, K; Nguyen, C; Perlman, O; Sedykh, M; Weigand-Whittier, J; Zaiss, M | 1 |
| Achawal, S; Barry, A; Beltran-Alvarez, P; Deepak, S; Feugere, L; Green, V; Greenman, J; Hosni, I; Iles, A; Moursi, A; Rajaraman, C; Samuel, SF; Scott, IS; Sennett, CJ; Stead, LF; Wade, MA; Wollenberg Valero, KC | 1 |
| Chen, JP; Chen, SR; Cheng, WY; Chiao, MT; Dai, XJ; Hsieh, WY; Lee, CH; Liang, YJ; Lin, GS; Liu, BS; Mao, TF; Shen, CC | 1 |
| Abbasi, S; Abd El-Wahab, A; Abdallah, M; Abebe, G; Aca-Aca, G; Adama, S; Adefegha, SA; Adidigue-Ndiome, R; Adiseshaiah, P; Adrario, E; Aghajanian, C; Agnese, W; Ahmad, A; Ahmad, I; Ahmed, MFE; Akcay, OF; Akinmoladun, AC; Akutagawa, T; Alakavuklar, MA; Álava-Rabasa, S; Albaladejo-Florín, MJ; Alexandra, AJE; Alfawares, R; Alferiev, IS; Alghamdi, HS; Ali, I; Allard, B; Allen, JD; Almada, E; Alobaid, A; Alonso, GL; Alqahtani, YS; Alqarawi, W; Alsaleh, H; Alyami, BA; Amaral, BPD; Amaro, JT; Amin, SAW; Amodio, E; Amoo, ZA; Andia Biraro, I; Angiolella, L; Anheyer, D; Anlay, DZ; Annex, BH; Antonio-Aguirre, B; Apple, S; Arbuznikov, AV; Arinsoy, T; Armstrong, DK; Ash, S; Aslam, M; Asrie, F; Astur, DC; Atzrodt, J; Au, DW; Aucoin, M; Auerbach, EJ; Azarian, S; Ba, D; Bai, Z; Baisch, PRM; Balkissou, AD; Baltzopoulos, V; Banaszewski, M; Banerjee, S; Bao, Y; Baradwan, A; Barandika, JF; Barger, PM; Barion, MRL; Barrett, CD; Basudan, AM; Baur, LE; Baz-Rodríguez, SA; Beamer, P; Beaulant, A; Becker, DF; Beckers, C; Bedel, J; Bedlack, R; Bermúdez de Castro, JM; Berry, JD; Berthier, C; Bhattacharya, D; Biadgo, B; Bianco, G; Bianco, M; Bibi, S; Bigliardi, AP; Billheimer, D; Birnie, DH; Biswas, K; Blair, HC; Bognetti, P; Bolan, PJ; Bolla, JR; Bolze, A; Bonnaillie, P; Borlimi, R; Bórquez, J; Bottari, NB; Boulleys-Nana, JR; Brighetti, G; Brodeur, GM; Budnyak, T; Budnyk, S; Bukirwa, VD; Bulman, DM; Burm, R; Busman-Sahay, K; Butcher, TW; Cai, C; Cai, H; Cai, L; Cairati, M; Calvano, CD; Camacho-Ordóñez, A; Camela, E; Cameron, T; Campbell, BS; Cansian, RL; Cao, Y; Caporale, AS; Carciofi, AC; Cardozo, V; Carè, J; Carlos, AF; Carozza, R; Carroll, CJW; Carsetti, A; Carubelli, V; Casarotta, E; Casas, M; Caselli, G; Castillo-Lora, J; Cataldi, TRI; Cavalcante, ELB; Cavaleiro, A; Cayci, Z; Cebrián-Tarancón, C; Cedrone, E; Cella, D; Cereda, C; Ceretti, A; Ceroni, M; Cha, YH; Chai, X; Chang, EF; Chang, TS; Chanteux, H; Chao, M; Chaplin, BP; Chaturvedi, S; Chaturvedi, V; Chaudhary, DK; Chen, A; Chen, C; Chen, HY; Chen, J; Chen, JJ; Chen, K; Chen, L; Chen, Q; Chen, R; Chen, SY; Chen, TY; Chen, WM; Chen, X; Chen, Y; Cheng, G; Cheng, GJ; Cheng, J; Cheng, YH; Cheon, HG; Chew, KW; Chhoker, S; Chiu, WN; Choi, ES; Choi, MJ; Choi, SD; Chokshi, S; Chorny, M; Chu, KI; Chu, WJ; Church, AL; Cirrincione, A; Clamp, AR; Cleff, MB; Cohen, M; Coleman, RL; Collins, SL; Colombo, N; Conduit, N; Cong, WL; Connelly, MA; Connor, J; Cooley, K; Correa Ramos Leal, I; Cose, S; Costantino, C; Cottrell, M; Cui, L; Cundall, J; Cutaia, C; Cutler, CW; Cuypers, ML; da Silva Júnior, FMR; Dahal, RH; Damiani, E; Damtie, D; Dan-Li, W; Dang, Z; Dasa, SSK; Davin, A; Davis, DR; de Andrade, CM; de Jong, PL; de Oliveira, D; de Paula Dorigam, JC; Dean, A; Deepa, M; Delatour, C; Dell'Aiera, S; Delley, MF; den Boer, RB; Deng, L; Deng, Q; Depner, RM; Derdau, V; Derici, U; DeSantis, AJ; Desmarini, D; Diffo-Sonkoue, L; Divizia, M; Djenabou, A; Djordjevic, JT; Dobrovolskaia, MA; Domizi, R; Donati, A; Dong, Y; Dos Santos, M; Dos Santos, MP; Douglas, RG; Duarte, PF; Dullaart, RPF; Duscha, BD; Edwards, LA; Edwards, TE; Eichenwald, EC; El-Baba, TJ; Elashiry, M; Elashiry, MM; Elashry, SH; Elliott, A; Elsayed, R; Emerson, MS; Emmanuel, YO; Emory, TH; Endale-Mangamba, LM; Enten, GA; Estefanía-Fernández, K; Estes, JD; Estrada-Mena, FJ; Evans, S; Ezra, L; Faria de, RO; Farraj, AK; Favre, C; Feng, B; Feng, J; Feng, L; Feng, W; Feng, X; Feng, Z; Fernandes, CLF; Fernández-Cuadros, ME; Fernie, AR; Ferrari, D; Florindo, PR; Fong, PC; Fontes, EPB; Fontinha, D; Fornari, VJ; Fox, NP; Fu, Q; Fujitaka, Y; Fukuhara, K; Fumeaux, T; Fuqua, C; Fustinoni, S; Gabbanelli, V; Gaikwad, S; Gall, ET; Galli, A; Gancedo, MA; Gandhi, MM; Gao, D; Gao, K; Gao, M; Gao, Q; Gao, X; Gao, Y; Gaponenko, V; Garber, A; Garcia, EM; García-Campos, C; García-Donas, J; García-Pérez, AL; Gasparri, F; Ge, C; Ge, D; Ge, JB; Ge, X; George, I; George, LA; Germani, G; Ghassemi Tabrizi, S; Gibon, Y; Gillent, E; Gillies, RS; Gilmour, MI; Goble, S; Goh, JC; Goiri, F; Goldfinger, LE; Golian, M; Gómez, MA; Gonçalves, J; Góngora-García, OR; Gonul, I; González, MA; Govers, TM; Grant, PC; Gray, EH; Gray, JE; Green, MS; Greenwald, I; Gregory, MJ; Gretzke, D; Griffin-Nolan, RJ; Griffith, DC; Gruppen, EG; Guaita, A; Guan, P; Guan, X; Guerci, P; Guerrero, DT; Guo, M; Guo, P; Guo, R; Guo, X; Gupta, J; Guz, G; Hajizadeh, N; Hamada, H; Haman-Wabi, AB; Han, TT; Hannan, N; Hao, S; Harjola, VP; Harmon, M; Hartmann, MSM; Hartwig, JF; Hasani, M; Hawthorne, WJ; Haykal-Coates, N; Hazari, MS; He, DL; He, P; He, SG; Héau, C; Hebbar Kannur, K; Helvaci, O; Heuberger, DM; Hidalgo, F; Hilty, MP; Hirata, K; Hirsch, A; Hoffman, AM; Hoffmann, JF; Holloway, RW; Holmes, RK; Hong, S; Hongisto, M; Hopf, NB; Hörlein, R; Hoshino, N; Hou, Y; Hoven, NF; Hsieh, YY; Hsu, CT; Hu, CW; Hu, JH; Hu, MY; Hu, Y; Hu, Z; Huang, C; Huang, D; Huang, DQ; Huang, L; Huang, Q; Huang, R; Huang, S; Huang, SC; Huang, W; Huang, Y; Huffman, KM; Hung, CH; Hung, CT; Huurman, R; Hwang, SM; Hyun, S; Ibrahim, AM; Iddi-Faical, A; Immordino, P; Isla, MI; Jacquemond, V; Jacques, T; Jankowska, E; Jansen, JA; Jäntti, T; Jaque-Fernandez, F; Jarvis, GA; Jatt, LP; Jeon, JW; Jeong, SH; Jhunjhunwala, R; Ji, F; Jia, X; Jia, Y; Jian-Bo, Z; Jiang, GD; Jiang, L; Jiang, W; Jiang, WD; Jiang, Z; Jiménez-Hoyos, CA; Jin, S; Jobling, MG; John, CM; John, T; Johnson, CB; Jones, KI; Jones, WS; Joseph, OO; Ju, C; Judeinstein, P; Junges, A; Junnarkar, M; Jurkko, R; Kaleka, CC; Kamath, AV; Kang, X; Kantsadi, AL; Kapoor, M; Karim, Z; Kashuba, ADM; Kassa, E; Kasztura, M; Kataja, A; Katoh, T; Kaufman, JS; Kaupp, M; Kehinde, O; Kehrenberg, C; Kemper, N; Kerr, CW; Khan, AU; Khan, MF; Khan, ZUH; Khojasteh, SC; Kilburn, S; Kim, CG; Kim, DU; Kim, DY; Kim, HJ; Kim, J; Kim, OH; Kim, YH; King, C; Klein, A; Klingler, L; Knapp, AK; Ko, TK; Kodavanti, UP; Kolla, V; Kong, L; Kong, RY; Kong, X; Kore, S; Kortz, U; Korucu, B; Kovacs, A; Krahnert, I; Kraus, WE; Kuang, SY; Kuehn-Hajder, JE; Kurz, M; Kuśtrowski, P; Kwak, YD; Kyttaris, VC; Laga, SM; Laguerre, A; Laloo, A; Langaro, MC; Langham, MC; Lao, X; Larocca, MC; Lassus, J; Lattimer, TA; Lazar, S; Le, MH; Leal, DB; Leal, M; Leary, A; Ledermann, JA; Lee, JF; Lee, MV; Lee, NH; Leeds, CM; Leeds, JS; Lefrandt, JD; Leicht, AS; Leonard, M; Lev, S; Levy, K; Li, B; Li, C; Li, CM; Li, DH; Li, H; Li, J; Li, L; Li, LJ; Li, N; Li, P; Li, T; Li, X; Li, XH; Li, XQ; Li, XX; Li, Y; Li, Z; Li, ZY; Liao, YF; Lin, CC; Lin, MH; Lin, Y; Ling, Y; Links, TP; Lira-Romero, E; Liu, C; Liu, D; Liu, H; Liu, J; Liu, L; Liu, LP; Liu, M; Liu, T; Liu, W; Liu, X; Liu, XH; Liu, Y; Liuwantara, D; Ljumanovic, N; Lobo, L; Lokhande, K; Lopes, A; Lopes, RMRM; López-Gutiérrez, JC; López-Muñoz, MJ; López-Santamaría, M; Lorenzo, C; Lorusso, D; Losito, I; Lu, C; Lu, H; Lu, HZ; Lu, SH; Lu, SN; Lu, Y; Lu, ZY; Luboga, F; Luo, JJ; Luo, KL; Luo, Y; Lutomski, CA; Lv, W; M Piedade, MF; Ma, J; Ma, JQ; Ma, JX; Ma, N; Ma, P; Ma, S; Maciel, M; Madureira, M; Maganaris, C; Maginn, EJ; Mahnashi, MH; Maierhofer, M; Majetschak, M; Malla, TR; Maloney, L; Mann, DL; Mansuri, A; Marelli, E; Margulis, CJ; Marrella, A; Martin, BL; Martín-Francés, L; Martínez de Pinillos, M; Martínez-Navarro, EM; Martinez-Quintanilla Jimenez, D; Martínez-Velasco, A; Martínez-Villaseñor, L; Martinón-Torres, M; Martins, BA; Massongo, M; Mathew, AP; Mathews, D; Matsui, J; Matsumoto, KI; Mau, T; Maves, RC; Mayclin, SJ; Mayer, JM; Maynard, ND; Mayr, T; Mboowa, MG; McEvoy, MP; McIntyre, RC; McKay, JA; McPhail, MJW; McVeigh, AL; Mebazaa, A; Medici, V; Medina, DN; Mehmood, T; Mei-Li, C; Melku, M; Meloncelli, S; Mendes, GC; Mendoza-Velásquez, C; Mercadante, R; Mercado, MI; Merenda, MEZ; Meunier, J; Mi, SL; Michels, M; Mijatovic, V; Mikhailov, V; Milheiro, SA; Miller, DC; Ming, F; Mitsuishi, M; Miyashita, T; Mo, J; Mo, S; Modesto-Mata, M; Moeller, S; Monte, A; Monteiro, L; Montomoli, J; Moore, EE; Moore, HB; Moore, PK; Mor, MK; Moratalla-López, N; Moratilla Lapeña, L; Moreira, R; Moreno, MA; Mörk, AC; Morton, M; Mosier, JM; Mou, LH; Mougharbel, AS; Muccillo-Baisch, AL; Muñoz-Serrano, AJ; Mustafa, B; Nair, GM; Nakanishi, I; Nakanjako, D; Naraparaju, K; Nawani, N; Neffati, R; Neil, EC; Neilipovitz, D; Neira-Borrajo, I; Nelson, MT; Nery, PB; Nese, M; Nguyen, F; Nguyen, MH; Niazy, AA; Nicolaï, J; Nogueira, F; Norbäck, D; Novaretti, JV; O'Donnell, T; O'Dowd, A; O'Malley, DM; Oaknin, A; Ogata, K; Ohkubo, K; Ojha, M; Olaleye, MT; Olawande, B; Olomo, EJ; Ong, EWY; Ono, A; Onwumere, J; Ortiz Bibriesca, DM; Ou, X; Oza, AM; Ozturk, K; Özütemiz, C; Palacio-Pastrana, C; Palaparthi, A; Palevsky, PM; Pan, K; Pantanetti, S; Papachristou, DJ; Pariani, A; Parikh, CR; Parissis, J; Paroul, N; Parry, S; Patel, N; Patel, SM; Patel, VC; Pawar, S; Pefura-Yone, EW; Peixoto Andrade, BCO; Pelepenko, LE; Peña-Lora, D; Peng, S; Pérez-Moro, OS; Perez-Ortiz, AC; Perry, LM; Peter, CM; Phillips, NJ; Phillips, P; Pia Tek, J; Piner, LW; Pinto, EA; Pinto, SN; Piyachaturawat, P; Poka-Mayap, V; Polledri, E; Poloni, TE; Ponessa, G; Poole, ST; Post, AK; Potter, TM; Pressly, BB; Prouty, MG; Prudêncio, M; Pulkki, K; Pupier, C; Qian, H; Qian, ZP; Qiu, Y; Qu, G; Rahimi, S; Rahman, AU; Ramadan, H; Ramanna, S; Ramirez, I; Randolph, GJ; Rasheed, A; Rault, J; Raviprakash, V; Reale, E; Redpath, C; Rema, V; Remucal, CK; Remy, D; Ren, T; Ribeiro, LB; Riboli, G; Richards, J; Rieger, V; Rieusset, J; Riva, A; Rivabella Maknis, T; Robbins, JL; Robinson, CV; Roche-Campo, F; Rodriguez, R; Rodríguez-de-Cía, J; Rollenhagen, JE; Rosen, EP; Rub, D; Rubin, N; Rubin, NT; Ruurda, JP; Saad, O; Sabell, T; Saber, SE; Sabet, M; Sadek, MM; Saejio, A; Salinas, RM; Saliu, IO; Sande, D; Sang, D; Sangenito, LS; Santos, ALSD; Sarmiento Caldas, MC; Sassaroli, S; Sassi, V; Sato, J; Sauaia, A; Saunders, K; Saunders, PR; Savarino, SJ; Scambia, G; Scanlon, N; Schetinger, MR; Schinkel, AFL; Schladweiler, MC; Schofield, CJ; Schuepbach, RA; Schulz, J; Schwartz, N; Scorcella, C; Seeley, J; Seemann, F; Seinige, D; Sengoku, T; Seravalli, J; Sgromo, B; Shaheen, MY; Shan, L; Shanmugam, S; Shao, H; Sharma, S; Shaw, KJ; Shen, BQ; Shen, CH; Shen, P; Shen, S; Shen, Y; Shen, Z; Shi, J; Shi-Li, L; Shimoda, K; Shoji, Y; Shun, C; Silva, MA; Silva-Cardoso, J; Simas, NK; Simirgiotis, MJ; Sincock, SA; Singh, MP; Sionis, A; Siu, J; Sivieri, EM; Sjerps, MJ; Skoczen, SL; Slabon, A; Slette, IJ; Smith, MD; Smith, S; Smith, TG; Snapp, KS; Snow, SJ; Soares, MCF; Soberman, D; Solares, MD; Soliman, I; Song, J; Sorooshian, A; Sorrell, TC; Spinar, J; Staudt, A; Steinhart, C; Stern, ST; Stevens, DM; Stiers, KM; Stimming, U; Su, YG; Subbian, V; Suga, H; Sukhija-Cohen, A; Suksamrarn, A; Suksen, K; Sun, J; Sun, M; Sun, P; Sun, W; Sun, XF; Sun, Y; Sundell, J; Susan, LF; Sutjarit, N; Swamy, KV; Swisher, EM; Sykes, C; Takahashi, JA; Talmor, DS; Tan, B; Tan, ZK; Tang, L; Tang, S; Tanner, JJ; Tanwar, M; Tarazi, Z; Tarvasmäki, T; Tay, FR; Teketel, A; Temitayo, GI; Thersleff, T; Thiessen Philbrook, H; Thompson, LC; Thongon, N; Tian, B; Tian, F; Tian, Q; Timothy, AT; Tingle, MD; Titze, IR; Tolppanen, H; Tong, W; Toyoda, H; Tronconi, L; Tseng, CH; Tu, H; Tu, YJ; Tung, SY; Turpault, S; Tuynman, JB; Uemoto, AT; Ugurlu, M; Ullah, S; Underwood, RS; Ungell, AL; Usandizaga-Elio, I; Vakonakis, I; van Boxel, GI; van den Beucken, JJJP; van der Boom, T; van Slegtenhorst, MA; Vanni, JR; Vaquera, A; Vasconcellos, RS; Velayos, M; Vena, R; Ventura, G; Verso, MG; Vincent, RP; Vitale, F; Vitali, S; Vlek, SL; Vleugels, MPH; Volkmann, N; Vukelic, M; Wagner Mackenzie, B; Wairagala, P; Waller, SB; Wan, J; Wan, MT; Wan, Y; Wang, CC; Wang, H; Wang, J; Wang, JF; Wang, K; Wang, L; Wang, M; Wang, S; Wang, WM; Wang, X; Wang, Y; Wang, YD; Wang, YF; Wang, Z; Wang, ZG; Warriner, K; Weberpals, JI; Weerachayaphorn, J; Wehrli, FW; Wei, J; Wei, KL; Weinheimer, CJ; Weisbord, SD; Wen, S; Wendel Garcia, PD; Williams, JW; Williams, R; Winkler, C; Wirman, AP; Wong, S; Woods, CM; Wu, B; Wu, C; Wu, F; Wu, P; Wu, S; Wu, Y; Wu, YN; Wu, ZH; Wurtzel, JGT; Xia, L; Xia, Z; Xia, ZZ; Xiao, H; Xie, C; Xin, ZM; Xing, Y; Xing, Z; Xu, S; Xu, SB; Xu, T; Xu, X; Xu, Y; Xue, L; Xun, J; Yaffe, MB; Yalew, A; Yamamoto, S; Yan, D; Yan, H; Yan, S; Yan, X; Yang, AD; Yang, E; Yang, H; Yang, J; Yang, JL; Yang, K; Yang, M; Yang, P; Yang, Q; Yang, S; Yang, W; Yang, X; Yang, Y; Yao, JC; Yao, WL; Yao, Y; Yaqub, TB; Ye, J; Ye, W; Yen, CW; Yeter, HH; Yin, C; Yip, V; Yong-Yi, J; Yu, HJ; Yu, MF; Yu, S; Yu, W; Yu, WW; Yu, X; Yuan, P; Yuan, Q; Yue, XY; Zaia, AA; Zakhary, SY; Zalwango, F; Zamalloa, A; Zamparo, P; Zampini, IC; Zani, JL; Zeitoun, R; Zeng, N; Zenteno, JC; Zepeda-Palacio, C; Zhai, C; Zhang, B; Zhang, G; Zhang, J; Zhang, K; Zhang, Q; Zhang, R; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, B; Zhao, D; Zhao, G; Zhao, H; Zhao, Q; Zhao, R; Zhao, S; Zhao, T; Zhao, X; Zhao, XA; Zhao, Y; Zhao, Z; Zheng, Z; Zhi-Min, G; Zhou, CL; Zhou, HD; Zhou, J; Zhou, W; Zhou, XQ; Zhou, Z; Zhu, C; Zhu, H; Zhu, L; Zhu, Y; Zitzmann, N; Zou, L; Zou, Y | 1 |
| Barry, A; Beltran-Alvarez, P; Greenman, J; Samuel, SF | 1 |
| Banasavadi-Siddegowda, YK; Bryant, JP; Heiss, J | 1 |
| Albrecht, J; Szeliga, M | 1 |
| Heimberger, AB; Hodges, TR; Shen, J; Song, R; Zhao, H | 1 |
| Chen, A; Huang, X; Jiang, B; Li, Q; Lin, F; Liu, M; Ma, H; Ouyang, C; Shi, M; Suleman, M; Wang, H; Wang, J; Wen, S; Zhang, J; Zhang, Y; Zhao, W; Zhou, H; Zhou, L | 1 |
| Chrétien, F; Dezamis, E; Dhermain, F; Saffroy, R; Tauziède-Espariat, A; Tourne, M; Varlet, P | 1 |
| Das, PP; Hii, L; Law, RHP; Lin, W; Mann, JR; Steer, DL; Udugama, M; Voon, HPJ; Wong, LH | 1 |
| Ai, C; Dong, F; Gao, W; Huo, D; Kang, C; Kong, Y; Li, Q; Li, W; Liu, W; Liu, X; Sun, X; Wang, W; Wang, X; Wu, X; Yang, C; Zhou, Y | 1 |
| Abaitua, F; Bomalaski, J; Crook, T; Hajitou, A; Hajji, N; Khozoie, C; O'Neill, K; Przystal, JM; Renziehausen, A; Suwan, K; Syed, N; Szlosarek, P; Want, E; Zeng, Q | 1 |
| Carvalho, IC; Carvalho, SM; Florentino, RM; Mansur, AAP; Mansur, HS | 1 |
| Debets, R; French, PJ; Sillevis Smitt, PAE; van Brakel, M; Weenink, B; Wijers, R | 1 |
| An, S; Bai, CZ; Choi, S; Lee, Y; Nam, K; Park, JS | 1 |
| Adamopoulos, C; Boviatsis, E; Chatziandreou, I; El-Habr, EA; Fragkou, P; Korkolopoulou, P; Levidou, G; Patsouris, E; Petraki, K; Piperi, C; Saetta, A; Sakalidou, M; Samaras, V; Themistocleous, MS; Vrettakos, G; Zisakis, A | 1 |
| Kato Kaneko, M; Kato, Y; Ogasawara, S | 1 |
| Ding, Q; Fathallah-Shaykh, HM; Friedman, GK; Gillespie, GY; Han, X; King, PH; Li, R; Nabors, LB; Province, P; Wheeler, CG; Yang, X; You, Z; Zhang, W; Zhao, X | 1 |
| Kalinovsky, T; Niedzwiecki, A; Rath, M; Roomi, MW | 1 |
| D'Abaco, GM; Drummond, KJ; Feleppa, F; Gonzales, M; Gorelik, A; Kaye, AH; Liubinas, SV; Moffat, BM; Morokoff, AP; Nowell, CJ; O'Brien, TJ | 1 |
| Kato, Y | 1 |
| Drozak, J; Jagielski, AK; Kunz-Schugart, LA; Olchowik, M; Pavlyk, I; Pereverzieva, G; Redowicz, MJ; Rzhepetskyy, Y; Stasyk, O; Wasik, A | 1 |
| Hayashi, Y; Iguchi, Y; Kitamatsu, M; Matsui, H; Michiue, H; Nishiki, T; Takenaka, F | 1 |
| Choi, E; Kim, HA; Kim, YH; Lee, HL; Lee, M | 1 |
| Buhrman, JS; Gemeinhart, RA; Liu, Y; Rayahin, JE; Zhang, Y | 1 |
| Choy, CT; Loong, HHF; Wong, CH | 1 |
| Eberhardt, A; Hansen, JN; Koster, J; Li, X; Livingstone, E; Lotta, LT; Qian, K; Schor, NF; Valentijn, LJ; Wang, S; Zheng, YG | 1 |
| ElAyeb, M; Nilges, M; Othman, H; Srairi-Abid, N; Wieninger, SA | 1 |
| Bae, Y; Choi, JS; Han, J; Ko, KS; Lee, S; Rhim, HS | 1 |
| Black, KL; Espinoza, AJ; Hu, J; Irvin, DK; Ko, MK; Konda, BM; Ong, JM; Sacapano, MR; Shu, Y; Wang, X; Yin, D | 1 |
| Körner, M; Reubi, JC | 1 |
| Darzy, KH; Shalet, SM; Thorner, MO | 1 |
| Pollard, PJ; Ratcliffe, PJ | 1 |
| Heth, J; Hoff, JT; Hua, Y; Keep, RF; Muraszko, KM; Tang, L; Xi, G | 1 |
| Balss, J; Capper, D; Hartmann, C; von Deimling, A; Zentgraf, H | 1 |
| Bennett, BD; Bittinger, MA; Cantley, LC; Dang, L; Driggers, EM; Fantin, VR; Gross, S; Jang, HG; Jin, S; Keenan, MC; Liau, LM; Marks, KM; Prins, RM; Rabinowitz, JD; Su, SM; Thompson, CB; Vander Heiden, MG; Ward, PS; White, DW; Yen, KE | 1 |
| Reitman, ZJ; Yan, H | 1 |
| Essig, M; Hartmann, C; Mawrin, C; Meyer, J; Schmieder, K; Seiz, M; Tuettenberg, J; von Deimling, A | 1 |
| Benedetti, GF; Camargo, AC; de Oliveira, EF; Guerreiro, JR; Lameu, C; Lebrun, I; Silva, CA; Ulrich, H | 1 |
| Bremer, J; Capper, D; Harter, PN; Hartmann, C; Jeibmann, A; Reuss, D; Sahm, F; Schittenhelm, J; von Deimling, A | 1 |
| Akcan, M; Clark, RJ; Craik, DJ; Daly, NL; Hansen, SJ; Olson, JM; Stroud, MR | 1 |
| Almeida, JR; Almeida, LO; Casartelli, C; Clara, CA; Custódio, AC; Pinto, GR; Rey, JA; Santos, MJ | 1 |
| Hainfellner, JA; Höftberger, R; Preusser, M; Stary, S; Streubel, B; Wöhrer, A | 1 |
| Klaassen, M; Kleinschmidt-DeMasters, BK; Nag, K; Sippel, TR; Tsvankin, V; Waziri, A; White, J | 1 |
| An, N; Fu, Y; Hu, C; Huang, R; Liang, A; Zheng, S; Zheng, Y | 1 |
| Chemaitilly, W; Hua, C; Lukose, RC; Merchant, TE; Wu, S | 1 |
| An, S; Bai, CZ; Choi, S; Nam, K; Park, JS | 1 |
| Hoff, JT; Hua, Y; Keep, RF; Schallert, T; Xi, G | 1 |
| Bornemann, A; Dietzmann, K; Firsching, R; Mawrin, C; Romeike, BF; Schneider, T; Sellhaus, B; von Deimling, A; Wiedemann, FR | 1 |
| Fewel, ME; Hoff, JT; Hua, Y; Keep, RF; Muraszko, KM; Schallert, T; Tang, LL; Xi, GH | 1 |
| Aimaretti, G; Ambrosio, MR; Bianchi, A; Cannavo, S; De Marinis, L; degli Uberti, EC; Di Somma, C; Fusco, A; Ghigo, E; Giordano, G; Mantero, F; Scaroni, C | 1 |
| Darzy, KH; Pezzoli, SS; Shalet, SM; Thorner, MO | 1 |
| Amorim, J; Costa, S; Lima-Ramos, V; Lopes, JM; Pacheco-Figueiredo, L; Pardal, F; Reis, RM; Silva, A | 1 |
| Caciacli, F; Ciancetta, S; Ciccarelli, R | 1 |
| Ahmed, SR; Shalet, SM | 1 |
| el-Fakahany, EE; Hu, J; Lee, JH | 1 |
| Baserga, R; Burgaud, JL; Resnicoff, M | 1 |
| Asai, M; Kanba, S; Kato, R; Nakaki, T; Nakamura, R; Richelson, E; Sato, K; Shintani, F; Yagi, G | 1 |
| Schmidlin, A; Wiesinger, H | 1 |
| Bonfoco, E; Brüne, B; Nicotera, P | 1 |
| Black, KL; Matsukado, K; Nakano, S | 1 |
| Brennan, BM; Lissett, CA; Rahim, A; Saleem, S; Shalet, SM | 1 |
| Feldt-Rasmussen, U; Hertz, H; Lassen, S; Müller, J; Poulsen, HS; Schmiegelow, K; Schmiegelow, M | 1 |
| Corasaniti, MT; Finazzi-Agrò, A; Melino, G; Nisticò, G; Tartaglia, RL | 1 |
| Fujiwara, S; Fukui, M; Iwaki, T; Kanaide, H; Moriguchi, M; Natori, Y; Takeshita, I | 1 |
| Brauner, R; Fagioli, I; Rappaport, R | 1 |
| Ahmed, SR; Beardwell, CG; Shalet, SM | 1 |
| Savage, DC; Ward, PS | 1 |
| Brecher, ML; Cohen, ME; Duffner, PK; Gilani, BB; MacGillivray, MH; Panahon, A; Voorhess, ML | 1 |
| Costin, G; Fefferman, RA; Kogut, MD | 1 |
| Gács, G; Hervei, C; Kerpel-Fronius, E | 1 |
| Farbiszewski, R; Rzeczycki, W; Worowski, K | 1 |
| Fishman, MA; Peake, GT | 1 |
| He, J; Hou, LJ; Li, WQ; Li, YM; Liu, HM; Lu, YC; Wang, X; Wu, XJ; Xia, CY; Yan, HZ; Yang, DH; Yu, HY | 1 |
| Glas, M; Herrlinger, U; Kebir, S; Mack, F; Niessen, M; Schäfer, N; Schaub, C; Scheffler, B; Stuplich, M | 1 |
| Bähr, O; Hattingen, E; Pilatus, U; Ronellenfitsch, MW; Steidl, E; Steinbach, JP; Zanella, F | 1 |
| Glas, M; Herrlinger, U; Hundsberger, T; Kurzwelly, D; Nguyen-Huu, B; Rasch, K; Stuplich, M; Wiewrodt, D | 1 |
| Feng, X; Lin, N; Liu, H; Wang, J; Xu, X; Zhang, B | 1 |
| Jiang, X; Qin, K; Qin, L; Wang, J; Zeng, Y; Zou, Y | 1 |
| Bertalanffy, H; Bozinov, O; Kalk, JM; Krayenbühl, N; Sure, U; Woernle, CM | 1 |
| Gu, K; Wang, J; Zhai, X; Zhang, J | 1 |
| Cardona, AF; Reveiz, L; Rueda, JR | 1 |
| Li, A; Wang, H; Wang, J; Wang, Q | 1 |
| Bamberg, M; Koch, R; Krauseneck, P; Müller, B; Weller, M | 1 |
| Basso, U; Brandes, AA; Ermani, M; Jirillo, A; Koussis, H; Lonardi, S; Monfardini, S; Paris, MK; Pasetto, LM; Tosoni, A; Vastola, F | 1 |
| Yue, X; Zang, QC | 1 |
| He, C; Li, H; Qin, N; Yang, C | 1 |
| Bratengeier, K; Flentje, M; Kölbl, O; Ruprecht, K; Vince, GH; Vordermark, D | 1 |
| Weller, M | 1 |
| Flentje, M; Kölbl, O; Rieckmann, P; Roggendorf, W; Ruprecht, K; Vince, GH; Vordermark, D; Warmuth-Metz, M | 1 |
| Feun, LG; Heros, D; Herrera, C; Landy, H; Marini, A; Markoe, A; Robles, C; Savaraj, N | 1 |
| Kessinger, A | 1 |
| Seiler, RW | 3 |
| Markwalder, H; Seiler, RW; Zimmermann, A | 1 |
| Di Stefano, E; Gerosa, MA; Olivi, A | 1 |
| Calciati, A; Conte, PF; Giaccone, G; Musella, R | 1 |
| Barrere, M; Bes, A; Fanjaud, G; Geraud, G; Larrue, V | 1 |
| Baumann, N; Jacque, C; Kujas, M; Poisson, M; Raoul, M | 1 |
| Alonso, MT; Leyland-Jones, B; Marsoni, S; O'Dwyer, PJ | 1 |
| Addison, D; Benoit, B; Dennery, J; Grahovac, Z; Hugenholtz, H; Maroun, JA; Peterson, E; Richard, MT; Russell, N; Stewart, DJ | 1 |
| Dennery, J; Hopkins, HS; Hugenholtz, H; Montpetit, V; Nundy, D; Prior, J; Richard, MT; Stewart, DJ | 1 |
| Iwasa, H; Kohno, T; Matsutani, M; Satoh, F; Takakura, K; Yamamoto, H | 1 |
| Akanuma, A; Kohno, T; Maehara, T; Nakamura, O; Sano, K; Sato, F; Shitara, N; Takakura, K; Yamamoto, H | 1 |
| Canetta, R; D'Incalci, M; Franchin, G; Galligioni, E; Grigoletto, E; Rossi, C; Tirelli, U; Trovò, MG; Tumolo, S; Veronesi, A | 1 |
| Hildebrand, J | 1 |
| Baumelou, A; Habibi, B; Lopez, M; Marteau, R; Salmon, C; Serdaru, M; Vonlanthen, M | 1 |
| Kang, S; Li, J; Li, L | 1 |
| Ardizzoni, A; Giaccone, G; Haaxma-Reiche, H; Kirkpatrick, A; Postmus, PE; Quoix, E; Sahmoud, T; Smit, EF; van Zandwijk, N | 1 |
| Muggia, FM | 1 |
| Belanger, G; Benoit, B; DaSilva, V; Grahovac, Z; Hugenholtz, H; Richard, MT; Russell, N; Stewart, DJ | 1 |
| Muse, IM; Wiernik, PH | 1 |
| Amistà, P; Berti, F; Brandes, AA; Fiorentino, MV; Gardiman, M; Rigon, A; Rotilio, A; Scelzi, E; Zampieri, P | 1 |
| Beijnen, JH; Boogerd, W; Nooijen, WJ; van Tellingen, O | 1 |
| Diete, S; Dietzmann, K; Kirches, E; von Bossanyi, P; Warich-Kirches, M | 1 |
| Altavilla, G; Brandes, AA; Carollo, C; Chierichetti, F; Ermani, M; Florentino, MV; Rigon, A; Turazzi, S; Zampieri, P | 1 |
| Holm, B; Jensen, PB; Sehested, M | 1 |
| Betti, M; Corgna, E; Crinò, L; Darwish, S; Meacci, ML; Minotti, V; Palladino, MA; Tonato, M | 1 |
| Dichgans, J; Groscurth, P; Gulbins, E; Malipiero, U; Trepel, M; Weller, M | 1 |
| Boogerd, W; van der Sande, JJ; van Zandwijk, N | 1 |
| Bartussek, C; Naumann, U; Weller, M | 1 |
| Dichgans, J; Esser, P; Meyermann, R; Rieger, J; Rieger, L; Streffer, J; Weller, M; Winter, S | 1 |
| Clerico, M; Curran, D; Giaccone, G; Gregor, A; Groen, HJ; Haaxma-Reiche, H; Karnicka, H; Kirkpatrick, A; Lewinski, T; Postmus, PE; Sahmoud, T; Smit, EF; van Meerbeeck, J | 1 |
| Deininger, MH; Grote, E; Meyermann, R; Wickboldt, J | 1 |
| Fietkau, R | 1 |
| Wang, L; Yang, H; Ye, M | 1 |
| Chen, B; Hu, S; Huang, C | 1 |
| Gangji, D; Hildebrand, J; Machin, D; Nouwynck, C | 1 |
| Basugi, N; Nomura, K; Sano, K; Shitara, N; Takakura, K; Yamamoto, H | 1 |
| Buge, A; Huguenin, P; M'orin, P; Mathé, G; Palangie, T; Parrot, R; Poisson, M; Pouillart, P | 1 |
| Philippon, J; Poisson, M; Racadot, J; Sichez, JP; van Effenterre, R | 1 |
| Foley, JF; Kessinger, A; Lemon, HM | 2 |
| Hassoun, J; Paillas, JE; Pellet, W; Peragut, JC; Prince, MA | 1 |
| Bleher, EA; Markwalder, H; Seiler, RW; Zimmermann, A | 1 |
| Sano, K; Shitara, N; Takakura, K; Yamamoto, H | 1 |
| Henney, JE; Muggia, FM; Rozencweig, M; Von Hoff, DD | 1 |
| Gautier, H; Huguenin, P; Lheritier, J; Mathé, G; Morin, P; Palangie, T; Parrot, R; Poisson, M; Pouillart, P | 1 |
| Buge, A; Poisson, M; Pouillart, P | 1 |
| Herson, J; Ragab, A; Sexhauer, C; Starling, KA; Sullivan, MP; van Eys, J | 1 |
| Markwalder, H; Seiler, RW; Vassella, F | 1 |
| Bataini, JP; Mashaly, R; Metzger, J; Pertuiset, BF; Poisson, M; Pouillart, P | 1 |
| Bataini, JP; Hauw, JJ; Mashaly, R; Metzger, J; Pertuiset, BF; Poisson, M; Pouillart, P | 1 |
| Gutin, PH; Walker, MD | 1 |
| de Tribolet, N; Wagenknecht, L; Zander, E | 1 |
| Elie, A; Loubrieu, G; Ribadeau Dumas, JL | 1 |
| Aimard, G; Chassard, JL; Devic, M; Tommasi, M; Trouillas, P | 1 |
| Buge, A; Gautier, H; Huguenin, P; Morin, P; Palangie, T; Poisson, M; Pouillart, P | 1 |
| D'Estienne d'Orves, JF; Paillas, JE; Pellet, W; Pollet, JF | 1 |
| Buge, A; Gautier, H; Huguenin, P; Lheritier, J; Mathé, G; Morin, P; Parrot, R; Poisson, M; Pouillart, P; Thy, HT | 1 |
| Levin, VA; Wilson, CB | 1 |
| Brouty-Boye, G | 1 |
| Gauthier, H; Huguenin, P; Lheritier, J; Mathe, G; Morin, P; Parrot, R; Poisson, M; Pouillart, P; Thy, TH | 1 |
| Djuric, LJ; Jeremic, B; Jevremovic, S; Jovanovic, D; Mijatovic, LJ | 1 |
| Berendsen, HH; Haaxma-Reiche, H; Postmus, PE; Sleijfer, DT; Smit, EF | 1 |
| McVie, JG | 1 |
| Hildebrand, JG | 1 |
| Chen, CM; Chen, ZT; Lai, YK; Lee, WC; Lin, KY; Liu, HJ | 1 |
| Eden, T; Shaw, PJ | 1 |
| Butti, G; D'Incalci, M; Donelli, MG; Gaetani, P; Knerich, R; Rossi, C; Silvani, V; Zucchetti, M | 1 |
| De Boben, M; Diedrich, H; Freund, M; Ganser, A; Heil, G; Henke, M; Heyll, A; Hiddemann, W; Knauf, U; Koch, P | 1 |
| Heuser, K | 1 |
| Bogdahn, U; Dünisch, G; Löbering, HG; Martin, R; Mertens, HG; Weber, H; Zapf, J | 1 |
| Benoit, B; Grahovac, Z; Hugenholtz, H; Richard, M; Russell, N; Stewart, DJ | 1 |
| Bonardi, GM; Calciati, A; Donadio, M; Giaccone, G; Testore, F | 1 |
| Berendsen, HH; Haaxma-Reiche, H; Postmus, PE | 1 |
| Ali-Osman, F; Dougherty, D; Giblin, J; Rosenblum, ML | 1 |
| Dodion, P; Georges, P; Kenis, Y; Sanders, C | 1 |
| Alberdi, J; Arana, T; Carcavilla, LI; Eiras, J; Gómez Perún, J; Pisón, J | 1 |
| Fortner, CL; King, SA; Leyland-Jones, B; O'Dwyer, PJ | 1 |
| Bertsch, L; Bouldin, TW; Cush, S; Krigman, MR; Mahaley, MS; Whaley, RA | 1 |
| Benoit, B; DaSilva, V; Hugenholtz, H; Maroun, J; Richard, M; Russell, N; Stewart, DJ; Verma, S | 1 |
18 review(s) available for arginine and Brain Neoplasms
| Article | Year |
|---|---|
MicroRNA delivery systems in glioma therapy and perspectives: A systematic review.
Topics: Arginine; Brain Neoplasms; Glioma; Humans; Liposomes; MicroRNAs; Nanoparticles; Peptides; Temozolomide | 2022 |
Topics: 3T3-L1 Cells; A Kinase Anchor Proteins; Acetates; Achilles Tendon; Acute Kidney Injury; Acute Pain; Acyclic Monoterpenes; Adenine Nucleotides; Adhesins, Escherichia coli; Adipocytes; Adipocytes, Brown; Adipogenesis; Administration, Inhalation; Administration, Oral; Adrenal Cortex Hormones; Adsorption; Adult; Aeromonas hydrophila; Africa; Aged; Aged, 80 and over; Agrobacterium tumefaciens; Air; Air Pollutants; Air Pollution; Air Pollution, Indoor; Algorithms; Alkaloids; Alkynes; Allosteric Regulation; Amines; Amino Acid Sequence; Amino Acids; Amino Acids, Branched-Chain; Aminoisobutyric Acids; Aminopyridines; Amyotrophic Lateral Sclerosis; Anaerobic Threshold; Angiography; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animal Distribution; Animal Feed; Animal Nutritional Physiological Phenomena; Animals; Ankle Joint; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Inflammatory Agents; Antibodies, Bacterial; Antifungal Agents; Antimalarials; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antioxidants; Antiretroviral Therapy, Highly Active; Antiviral Agents; Aotidae; Apelin; Apoptosis; Arabidopsis Proteins; Argentina; Arginine; Artemisinins; Arthritis, Experimental; Arthritis, Rheumatoid; Arthroscopy; Aspergillus; Aspergillus niger; Asteraceae; Asthma; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; Auditory Cortex; Autoantibodies; Autophagy; Bacteria; Bacterial Infections; Bacterial Proteins; Bacterial Typing Techniques; Base Composition; Base Sequence; Basketball; Beclin-1; Benzhydryl Compounds; Benzimidazoles; Benzo(a)pyrene; Benzofurans; Benzoxazines; Bereavement; beta Catenin; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Betacoronavirus; Betaine; Binding Sites; Biofilms; Biological Assay; Biological Availability; Biological Evolution; Biomarkers; Biomechanical Phenomena; Biopolymers; Biopsy; Bismuth; Blood Glucose; Blood Platelets; Blood Pressure; Body Composition; Body Weight; Bone Marrow; Bone Marrow Cells; Bone Regeneration; Boron; Botrytis; Brain Ischemia; Brain Neoplasms; Brain-Derived Neurotrophic Factor; Brazil; Breast Neoplasms; Breath Tests; Bronchoalveolar Lavage Fluid; Burkholderia; C-Reactive Protein; Caenorhabditis elegans; Caenorhabditis elegans Proteins; Calcification, Physiologic; Calcium; Calcium Signaling; Calorimetry, Differential Scanning; Cameroon; Camptothecin; Candida; Candida albicans; Capillaries; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Carbohydrate Conformation; Carbon; Carbon Dioxide; Carbon Isotopes; Carcinoma, Ovarian Epithelial; Cardiac Output; Cardiomyopathy, Hypertrophic; Cardiotonic Agents; Cardiovascular Diseases; Caregivers; Carps; Case-Control Studies; Catalase; Catalysis; Cats; CD4 Lymphocyte Count; Cell Culture Techniques; Cell Differentiation; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Survival; Cells, Cultured; Cellulose; Centrosome; Ceratopogonidae; Chickens; Child; China; Cholera Toxin; Choline; Cholinesterases; Chromatography, High Pressure Liquid; Chromatography, Liquid; Chromatography, Micellar Electrokinetic Capillary; Chromatography, Reverse-Phase; Chronic Disease; Cinnamates; Cities; Citrates; Climate Change; Clinical Trials, Phase III as Topic; Coal; Coal Mining; Cohort Studies; Coinfection; Colchicine; Colony Count, Microbial; Colorectal Neoplasms; Coloring Agents; Common Cold; Complement Factor H; Computational Biology; Computer Simulation; Continuous Positive Airway Pressure; Contrast Media; Coordination Complexes; Coronary Artery Bypass; Coronavirus 3C Proteases; Coronavirus Infections; Coronavirus Protease Inhibitors; Corynebacterium glutamicum; Cosmetics; COVID-19; Creatinine; Cross-Sectional Studies; Crotonates; Crystallography, X-Ray; Cues; Culicidae; Culture Media; Curcuma; Cyclopentanes; Cyclopropanes; Cymbopogon; Cystine; Cytochrome P-450 CYP2B6; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C19 Inhibitors; Cytokines; Databases, Genetic; Death; Dendritic Cells; Density Functional Theory; Depsides; Diabetes Mellitus, Type 2; Diamond; Diarylheptanoids; Dibenzofurans; Dibenzofurans, Polychlorinated; Diclofenac; Diet; Dietary Carbohydrates; Dietary Supplements; Diffusion Magnetic Resonance Imaging; Dioxins; Diphenylamine; Disease Outbreaks; Disease Susceptibility; Disulfides; Dithiothreitol; Dizocilpine Maleate; DNA Methylation; DNA-Binding Proteins; DNA, Bacterial; Dogs; Dose-Response Relationship, Drug; Double-Blind Method; Doublecortin Protein; Drosophila melanogaster; Droughts; Drug Carriers; Drug Combinations; Drug Delivery Systems; Drug Liberation; Drug Resistance; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Dust; Dynactin Complex; Dysferlin; Echo-Planar Imaging; Echocardiography; Edaravone; Egypt; Elasticity; Electrodes; Electrolytes; Emodin; Emtricitabine; Endometriosis; Endothelium, Vascular; Endotoxins; Energy Metabolism; Energy Transfer; Enterobacteriaceae; Enterococcus faecalis; Enterotoxigenic Escherichia coli; Environmental Monitoring; Enzyme Inhibitors; Epidemiologic Factors; Epigenesis, Genetic; Erythrocytes; Escherichia coli; Escherichia coli Infections; Escherichia coli Vaccines; Esophageal Neoplasms; Esophagectomy; Esophagogastric Junction; Esterases; Esterification; Ethanol; Ethiopia; Ethnicity; Eucalyptus; Evidence-Based Practice; Exercise; Exercise Tolerance; Extracorporeal Membrane Oxygenation; Family; Fatty Acids; Feedback; Female; Ferric Compounds; Fibrin Fibrinogen Degradation Products; Filtration; Fish Diseases; Flavonoids; Flavonols; Fluorodeoxyglucose F18; Follow-Up Studies; Food Microbiology; Food Preservation; Forests; Fossils; Free Radical Scavengers; Freund's Adjuvant; Fruit; Fungi; Gallium; Gender Identity; Gene Expression Regulation; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Plant; Gene Knockdown Techniques; Genes, Bacterial; Genes, Plant; Genetic Predisposition to Disease; Genitalia; Genotype; Glomerulonephritis, IGA; Glottis; Glucocorticoids; Glucose; Glucuronides; Glutathione Transferase; Glycogen Synthase Kinase 3 beta; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Grassland; Guinea Pigs; Half-Life; Head Kidney; Heart Atria; Heart Rate; Heart Septum; HEK293 Cells; Hematopoietic Stem Cells; Hemodynamics; Hep G2 Cells; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Hepatocytes; Hesperidin; High-Frequency Ventilation; High-Temperature Requirement A Serine Peptidase 1; Hippocampus; Hirudins; History, 20th Century; History, 21st Century; HIV Infections; Homeostasis; Hominidae; Housing, Animal; Humans; Hydrocarbons, Brominated; Hydrogen Bonding; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydroxybutyrates; Hydroxyl Radical; Hypertension; Hypothyroidism; Image Interpretation, Computer-Assisted; Immunoconjugates; Immunogenic Cell Death; Indoles; Infant, Newborn; Infant, Premature; Infarction, Middle Cerebral Artery; Inflammation; Inflammation Mediators; Infrared Rays; Inhibitory Concentration 50; Injections, Intravenous; Interferon-gamma; Interleukin-23; Interleukin-4; Interleukin-6; Intermediate Filaments; Intermittent Claudication; Intestine, Small; Iridoid Glucosides; Iridoids; Iron; Isomerism; Isotope Labeling; Isoxazoles; Itraconazole; Kelch-Like ECH-Associated Protein 1; Ketoprofen; Kidney Failure, Chronic; Kinetics; Klebsiella pneumoniae; Lactams, Macrocyclic; Lactobacillus; Lactulose; Lakes; Lamivudine; Laparoscopy; Laparotomy; Laryngoscopy; Leucine; Limit of Detection; Linear Models; Lipid A; Lipopolysaccharides; Listeria monocytogenes; Liver; Liver Cirrhosis; Logistic Models; Longitudinal Studies; Losartan; Low Back Pain; Lung; Lupinus; Lupus Erythematosus, Systemic; Machine Learning; Macular Degeneration; Madin Darby Canine Kidney Cells; Magnetic Phenomena; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Magnetics; Malaria, Falciparum; Male; Mannans; MAP Kinase Signaling System; Mass Spectrometry; Melatonin; Membrane Glycoproteins; Membrane Proteins; Meniscectomy; Menisci, Tibial; Mephenytoin; Mesenchymal Stem Cells; Metal Nanoparticles; Metal-Organic Frameworks; Methionine; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Nude; Mice, Obese; Mice, Transgenic; Microbial Sensitivity Tests; Microcirculation; MicroRNAs; Microscopy, Video; Microtubules; Microvascular Density; Microwaves; Middle Aged; Minimally Invasive Surgical Procedures; Models, Animal; Models, Biological; Models, Molecular; Models, Theoretical; Molecular Docking Simulation; Molecular Structure; Molecular Weight; Morus; Mouth Floor; Multicenter Studies as Topic; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Muscle, Skeletal; Myocardial Ischemia; Myocardium; NAD; NADP; Nanocomposites; Nanoparticles; Naphthols; Nasal Lavage Fluid; Nasal Mucosa; Neisseria meningitidis; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasms, Experimental; Neural Stem Cells; Neuroblastoma; Neurofilament Proteins; Neurogenesis; Neurons; New York; NF-E2-Related Factor 2; NF-kappa B; Nicotine; Nitriles; Nitrogen; Nitrogen Fixation; North America; Observer Variation; Occupational Exposure; Ochrobactrum; Oils, Volatile; Olea; Oligosaccharides; Omeprazole; Open Field Test; Optimism; Oregon; Oryzias; Osmolar Concentration; Osteoarthritis; Osteoblasts; Osteogenesis; Ovarian Neoplasms; Ovariectomy; Oxadiazoles; Oxidation-Reduction; Oxidative Stress; Oxygen; Ozone; p38 Mitogen-Activated Protein Kinases; Pakistan; Pandemics; Particle Size; Particulate Matter; Patient-Centered Care; Pelargonium; Peptides; Perception; Peripheral Arterial Disease; Peroxides; Pets; Pharmaceutical Preparations; Pharmacogenetics; Phenobarbital; Phenols; Phenotype; Phosphates; Phosphatidylethanolamines; Phosphines; Phospholipids; Phosphorus; Phosphorylation; Photoacoustic Techniques; Photochemotherapy; Photosensitizing Agents; Phylogeny; Phytoestrogens; Pilot Projects; Plant Components, Aerial; Plant Extracts; Plant Immunity; Plant Leaves; Plant Oils; Plants, Medicinal; Plasmodium berghei; Plasmodium falciparum; Platelet Activation; Platelet Function Tests; Pneumonia, Viral; Poaceae; Pogostemon; Poloxamer; Poly I; Poly(ADP-ribose) Polymerase Inhibitors; Polychlorinated Biphenyls; Polychlorinated Dibenzodioxins; Polycyclic Compounds; Polyethylene Glycols; Polylysine; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Population Dynamics; Portasystemic Shunt, Transjugular Intrahepatic; Positron Emission Tomography Computed Tomography; Postoperative Complications; Postprandial Period; Potassium Cyanide; Predictive Value of Tests; Prefrontal Cortex; Pregnancy; Prepulse Inhibition; Prevalence; Procalcitonin; Prodrugs; Prognosis; Progression-Free Survival; Proline; Proof of Concept Study; Prospective Studies; Protein Binding; Protein Conformation; Protein Domains; Protein Folding; Protein Multimerization; Protein Sorting Signals; Protein Structure, Secondary; Proton Pump Inhibitors; Protozoan Proteins; Psychometrics; Pulse Wave Analysis; Pyridines; Pyrrolidines; Quality of Life; Quantum Dots; Quinoxalines; Quorum Sensing; Radiopharmaceuticals; Rain; Random Allocation; Randomized Controlled Trials as Topic; Rats; Rats, Sprague-Dawley; Rats, Wistar; RAW 264.7 Cells; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Receptor, PAR-1; Receptors, CXCR4; Receptors, Estrogen; Receptors, Glucocorticoid; Receptors, Interleukin-1; Receptors, Interleukin-17; Receptors, Notch; Recombinant Fusion Proteins; Recombinant Proteins; Reducing Agents; Reflex, Startle; Regional Blood Flow; Regression Analysis; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Tract Diseases; Retrospective Studies; Reverse Transcriptase Inhibitors; Rhinitis, Allergic; Risk Assessment; Risk Factors; Rituximab; RNA, Messenger; RNA, Ribosomal, 16S; ROC Curve; Rosmarinic Acid; Running; Ruthenium; Rutin; Sarcolemma; Sarcoma; Sarcopenia; Sarcoplasmic Reticulum; SARS-CoV-2; Scavenger Receptors, Class A; Schools; Seasons; Seeds; Sequence Analysis, DNA; Severity of Illness Index; Sex Factors; Shock, Cardiogenic; Short Chain Dehydrogenase-Reductases; Signal Transduction; Silver; Singlet Oxygen; Sinusitis; Skin; Skin Absorption; Small Molecule Libraries; Smoke; Socioeconomic Factors; Soil; Soil Microbiology; Solid Phase Extraction; Solubility; Solvents; Spain; Spectrometry, Mass, Electrospray Ionization; Spectroscopy, Fourier Transform Infrared; Speech; Speech Perception; Spindle Poles; Spleen; Sporothrix; Staphylococcal Infections; Staphylococcus aureus; Stereoisomerism; Stomach Neoplasms; Stress, Physiological; Stroke Volume; Structure-Activity Relationship; Substrate Specificity; Sulfonamides; Surface Properties; Surface-Active Agents; Surveys and Questionnaires; Survival Rate; T-Lymphocytes, Cytotoxic; Tandem Mass Spectrometry; Temperature; Tenofovir; Terpenes; Tetracycline; Tetrapleura; Textiles; Thermodynamics; Thiobarbituric Acid Reactive Substances; Thrombin; Thyroid Hormones; Thyroid Neoplasms; Tibial Meniscus Injuries; Time Factors; Tissue Distribution; Titanium; Toluidines; Tomography, X-Ray Computed; Tooth; Tramadol; Transcription Factor AP-1; Transcription, Genetic; Transfection; Transgender Persons; Translations; Treatment Outcome; Triglycerides; Ubiquinone; Ubiquitin-Specific Proteases; United Kingdom; United States; Up-Regulation; Vascular Stiffness; Veins; Ventricular Remodeling; Viral Load; Virulence Factors; Virus Replication; Vitis; Voice; Voice Quality; Wastewater; Water; Water Pollutants, Chemical; Water-Electrolyte Balance; Weather; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Young Adult; Zoogloea | 2022 |
Arginine methylation: the promise of a 'silver bullet' for brain tumours?
Topics: Antineoplastic Agents; Arginine; Brain Neoplasms; Enzyme Inhibitors; Humans; Methylation; Protein Processing, Post-Translational; Protein-Arginine N-Methyltransferases | 2021 |
Arginine Methylation in Brain Tumors: Tumor Biology and Therapeutic Strategies.
Topics: Arginine; Brain Neoplasms; Carcinogenesis; Humans; Methylation; Models, Biological; Protein-Arginine N-Methyltransferases | 2021 |
Roles of nitric oxide and polyamines in brain tumor growth.
Topics: Animals; Arginine; Brain Neoplasms; Humans; Nitric Oxide; Polyamines | 2021 |
Specific monoclonal antibodies against IDH1/2 mutations as diagnostic tools for gliomas.
Topics: Antibodies, Monoclonal; Arginine; Biomarkers, Tumor; Brain Neoplasms; Catalysis; Cytosol; Glioma; Glutarates; Humans; Immunohistochemistry; Isocitrate Dehydrogenase; Isocitrates; Ketoglutaric Acids; Mitochondria; Mutation; Oxidation-Reduction | 2015 |
Isocitrate dehydrogenase 1 and 2 mutations in cancer: alterations at a crossroads of cellular metabolism.
Topics: Animals; Arginine; Brain Neoplasms; Codon; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Genes, Tumor Suppressor; Glioblastoma; Glucose; Glutarates; Humans; Hypoxia; Isocitrate Dehydrogenase; Mutation; NADP; Neoplasms; Oligodendroglioma; Oncogenes; Signal Transduction; Up-Regulation | 2010 |
Mechanisms for nitric oxide-induced cell death: involvement of apoptosis.
Topics: AIDS Dementia Complex; Animals; Arginine; Astrocytes; Astrocytoma; Brain Neoplasms; Cytokines; Histocompatibility Antigens Class II; HIV Envelope Protein gp120; Humans; Immunocompetence; Nervous System Diseases; Neuroimmunomodulation; Nitric Oxide; Rats; Tumor Cells, Cultured | 1995 |
Chemotherapy for brain metastases from small cell lung cancer.
Topics: Antineoplastic Agents; Brain Neoplasms; Cisplatin; Cranial Irradiation; Humans; Lung Neoplasms; Randomized Controlled Trials as Topic; Small Cell Lung Carcinoma; Teniposide; Topotecan | 2012 |
[Standards and new developments in the chemotherapy of glioblastomas].
Topics: Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Chemotherapy, Adjuvant; Cytarabine; Dacarbazine; Decanoic Acids; DNA Modification Methylases; Glioblastoma; Humans; Nimustine; Polyesters; Promoter Regions, Genetic; Temozolomide; Teniposide | 2005 |
High dose chemotherapy with autologous bone marrow rescue for high grade gliomas of the brain: a potential for improvement in therapeutic results.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Brain Neoplasms; Carmustine; Combined Modality Therapy; Etoposide; Glioblastoma; Glioma; Humans; Lomustine; Teniposide | 1984 |
Teniposide: a review of 12 years of experience.
Topics: Adult; Animals; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cell Cycle; Cell Line; Child; Clinical Trials as Topic; Colonic Neoplasms; DNA, Neoplasm; Drug Evaluation, Preclinical; Drug Resistance; Humans; Leukemia; Lymphoma; Mice; Neoplasms; Neoplasms, Experimental; Neuroblastoma; Podophyllotoxin; Teniposide | 1984 |
Teniposide: overview of its therapeutic potential in adult cancers.
Topics: Acquired Immunodeficiency Syndrome; Adult; Brain Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Clinical Trials as Topic; Clinical Trials, Phase I as Topic; Etoposide; Female; Genital Neoplasms, Female; Hodgkin Disease; Humans; Leukemia; Lung Neoplasms; Lymphoma; Lymphoma, Non-Hodgkin; Neoplasms; Sarcoma, Kaposi; Teniposide | 1994 |
Acute promyelocytic leukemia after treatment of malignant glioma in a patient with von Recklinghausen's disease: case report and review of the literature.
Topics: Adult; Antineoplastic Agents, Phytogenic; Brain Neoplasms; Combined Modality Therapy; Cranial Irradiation; Glioblastoma; Humans; Leukemia, Promyelocytic, Acute; Leukemia, Radiation-Induced; Male; Neoplasms, Second Primary; Neurofibromatosis 1; Teniposide | 1996 |
VM 26 and VP 16-213: a comparative analysis.
Topics: Animals; Brain Neoplasms; Drug Evaluation; Etoposide; Humans; Kinetics; Leukemia; Lung Neoplasms; Lymphoma; Neoplasms, Experimental; Podophyllotoxin; Teniposide; Urinary Bladder Neoplasms | 1977 |
Chemotherapy: the agents in current use.
Topics: Antineoplastic Agents; Brain Neoplasms; Carmustine; Dacarbazine; Drug Therapy, Combination; Glioma; Humans; Lomustine; Medulloblastoma; Methotrexate; Nitrogen Mustard Compounds; Procarbazine; Semustine; Teniposide; Vincristine | 1975 |
Teniposide (VM-26) in brain tumors.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Humans; Remission Induction; Teniposide | 1992 |
Neuroblastoma with intracranial involvement: an ENSG Study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Child, Preschool; Cisplatin; Cranial Fossa, Posterior; Cyclophosphamide; Europe; Humans; Infant; Male; Neuroblastoma; Prevalence; Registries; Teniposide; Vincristine | 1992 |
31 trial(s) available for arginine and Brain Neoplasms
| Article | Year |
|---|---|
Topics: 3T3-L1 Cells; A Kinase Anchor Proteins; Acetates; Achilles Tendon; Acute Kidney Injury; Acute Pain; Acyclic Monoterpenes; Adenine Nucleotides; Adhesins, Escherichia coli; Adipocytes; Adipocytes, Brown; Adipogenesis; Administration, Inhalation; Administration, Oral; Adrenal Cortex Hormones; Adsorption; Adult; Aeromonas hydrophila; Africa; Aged; Aged, 80 and over; Agrobacterium tumefaciens; Air; Air Pollutants; Air Pollution; Air Pollution, Indoor; Algorithms; Alkaloids; Alkynes; Allosteric Regulation; Amines; Amino Acid Sequence; Amino Acids; Amino Acids, Branched-Chain; Aminoisobutyric Acids; Aminopyridines; Amyotrophic Lateral Sclerosis; Anaerobic Threshold; Angiography; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animal Distribution; Animal Feed; Animal Nutritional Physiological Phenomena; Animals; Ankle Joint; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Inflammatory Agents; Antibodies, Bacterial; Antifungal Agents; Antimalarials; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antioxidants; Antiretroviral Therapy, Highly Active; Antiviral Agents; Aotidae; Apelin; Apoptosis; Arabidopsis Proteins; Argentina; Arginine; Artemisinins; Arthritis, Experimental; Arthritis, Rheumatoid; Arthroscopy; Aspergillus; Aspergillus niger; Asteraceae; Asthma; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; Auditory Cortex; Autoantibodies; Autophagy; Bacteria; Bacterial Infections; Bacterial Proteins; Bacterial Typing Techniques; Base Composition; Base Sequence; Basketball; Beclin-1; Benzhydryl Compounds; Benzimidazoles; Benzo(a)pyrene; Benzofurans; Benzoxazines; Bereavement; beta Catenin; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Betacoronavirus; Betaine; Binding Sites; Biofilms; Biological Assay; Biological Availability; Biological Evolution; Biomarkers; Biomechanical Phenomena; Biopolymers; Biopsy; Bismuth; Blood Glucose; Blood Platelets; Blood Pressure; Body Composition; Body Weight; Bone Marrow; Bone Marrow Cells; Bone Regeneration; Boron; Botrytis; Brain Ischemia; Brain Neoplasms; Brain-Derived Neurotrophic Factor; Brazil; Breast Neoplasms; Breath Tests; Bronchoalveolar Lavage Fluid; Burkholderia; C-Reactive Protein; Caenorhabditis elegans; Caenorhabditis elegans Proteins; Calcification, Physiologic; Calcium; Calcium Signaling; Calorimetry, Differential Scanning; Cameroon; Camptothecin; Candida; Candida albicans; Capillaries; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Carbohydrate Conformation; Carbon; Carbon Dioxide; Carbon Isotopes; Carcinoma, Ovarian Epithelial; Cardiac Output; Cardiomyopathy, Hypertrophic; Cardiotonic Agents; Cardiovascular Diseases; Caregivers; Carps; Case-Control Studies; Catalase; Catalysis; Cats; CD4 Lymphocyte Count; Cell Culture Techniques; Cell Differentiation; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Survival; Cells, Cultured; Cellulose; Centrosome; Ceratopogonidae; Chickens; Child; China; Cholera Toxin; Choline; Cholinesterases; Chromatography, High Pressure Liquid; Chromatography, Liquid; Chromatography, Micellar Electrokinetic Capillary; Chromatography, Reverse-Phase; Chronic Disease; Cinnamates; Cities; Citrates; Climate Change; Clinical Trials, Phase III as Topic; Coal; Coal Mining; Cohort Studies; Coinfection; Colchicine; Colony Count, Microbial; Colorectal Neoplasms; Coloring Agents; Common Cold; Complement Factor H; Computational Biology; Computer Simulation; Continuous Positive Airway Pressure; Contrast Media; Coordination Complexes; Coronary Artery Bypass; Coronavirus 3C Proteases; Coronavirus Infections; Coronavirus Protease Inhibitors; Corynebacterium glutamicum; Cosmetics; COVID-19; Creatinine; Cross-Sectional Studies; Crotonates; Crystallography, X-Ray; Cues; Culicidae; Culture Media; Curcuma; Cyclopentanes; Cyclopropanes; Cymbopogon; Cystine; Cytochrome P-450 CYP2B6; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C19 Inhibitors; Cytokines; Databases, Genetic; Death; Dendritic Cells; Density Functional Theory; Depsides; Diabetes Mellitus, Type 2; Diamond; Diarylheptanoids; Dibenzofurans; Dibenzofurans, Polychlorinated; Diclofenac; Diet; Dietary Carbohydrates; Dietary Supplements; Diffusion Magnetic Resonance Imaging; Dioxins; Diphenylamine; Disease Outbreaks; Disease Susceptibility; Disulfides; Dithiothreitol; Dizocilpine Maleate; DNA Methylation; DNA-Binding Proteins; DNA, Bacterial; Dogs; Dose-Response Relationship, Drug; Double-Blind Method; Doublecortin Protein; Drosophila melanogaster; Droughts; Drug Carriers; Drug Combinations; Drug Delivery Systems; Drug Liberation; Drug Resistance; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Dust; Dynactin Complex; Dysferlin; Echo-Planar Imaging; Echocardiography; Edaravone; Egypt; Elasticity; Electrodes; Electrolytes; Emodin; Emtricitabine; Endometriosis; Endothelium, Vascular; Endotoxins; Energy Metabolism; Energy Transfer; Enterobacteriaceae; Enterococcus faecalis; Enterotoxigenic Escherichia coli; Environmental Monitoring; Enzyme Inhibitors; Epidemiologic Factors; Epigenesis, Genetic; Erythrocytes; Escherichia coli; Escherichia coli Infections; Escherichia coli Vaccines; Esophageal Neoplasms; Esophagectomy; Esophagogastric Junction; Esterases; Esterification; Ethanol; Ethiopia; Ethnicity; Eucalyptus; Evidence-Based Practice; Exercise; Exercise Tolerance; Extracorporeal Membrane Oxygenation; Family; Fatty Acids; Feedback; Female; Ferric Compounds; Fibrin Fibrinogen Degradation Products; Filtration; Fish Diseases; Flavonoids; Flavonols; Fluorodeoxyglucose F18; Follow-Up Studies; Food Microbiology; Food Preservation; Forests; Fossils; Free Radical Scavengers; Freund's Adjuvant; Fruit; Fungi; Gallium; Gender Identity; Gene Expression Regulation; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Plant; Gene Knockdown Techniques; Genes, Bacterial; Genes, Plant; Genetic Predisposition to Disease; Genitalia; Genotype; Glomerulonephritis, IGA; Glottis; Glucocorticoids; Glucose; Glucuronides; Glutathione Transferase; Glycogen Synthase Kinase 3 beta; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Grassland; Guinea Pigs; Half-Life; Head Kidney; Heart Atria; Heart Rate; Heart Septum; HEK293 Cells; Hematopoietic Stem Cells; Hemodynamics; Hep G2 Cells; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Hepatocytes; Hesperidin; High-Frequency Ventilation; High-Temperature Requirement A Serine Peptidase 1; Hippocampus; Hirudins; History, 20th Century; History, 21st Century; HIV Infections; Homeostasis; Hominidae; Housing, Animal; Humans; Hydrocarbons, Brominated; Hydrogen Bonding; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydroxybutyrates; Hydroxyl Radical; Hypertension; Hypothyroidism; Image Interpretation, Computer-Assisted; Immunoconjugates; Immunogenic Cell Death; Indoles; Infant, Newborn; Infant, Premature; Infarction, Middle Cerebral Artery; Inflammation; Inflammation Mediators; Infrared Rays; Inhibitory Concentration 50; Injections, Intravenous; Interferon-gamma; Interleukin-23; Interleukin-4; Interleukin-6; Intermediate Filaments; Intermittent Claudication; Intestine, Small; Iridoid Glucosides; Iridoids; Iron; Isomerism; Isotope Labeling; Isoxazoles; Itraconazole; Kelch-Like ECH-Associated Protein 1; Ketoprofen; Kidney Failure, Chronic; Kinetics; Klebsiella pneumoniae; Lactams, Macrocyclic; Lactobacillus; Lactulose; Lakes; Lamivudine; Laparoscopy; Laparotomy; Laryngoscopy; Leucine; Limit of Detection; Linear Models; Lipid A; Lipopolysaccharides; Listeria monocytogenes; Liver; Liver Cirrhosis; Logistic Models; Longitudinal Studies; Losartan; Low Back Pain; Lung; Lupinus; Lupus Erythematosus, Systemic; Machine Learning; Macular Degeneration; Madin Darby Canine Kidney Cells; Magnetic Phenomena; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Magnetics; Malaria, Falciparum; Male; Mannans; MAP Kinase Signaling System; Mass Spectrometry; Melatonin; Membrane Glycoproteins; Membrane Proteins; Meniscectomy; Menisci, Tibial; Mephenytoin; Mesenchymal Stem Cells; Metal Nanoparticles; Metal-Organic Frameworks; Methionine; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Nude; Mice, Obese; Mice, Transgenic; Microbial Sensitivity Tests; Microcirculation; MicroRNAs; Microscopy, Video; Microtubules; Microvascular Density; Microwaves; Middle Aged; Minimally Invasive Surgical Procedures; Models, Animal; Models, Biological; Models, Molecular; Models, Theoretical; Molecular Docking Simulation; Molecular Structure; Molecular Weight; Morus; Mouth Floor; Multicenter Studies as Topic; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Muscle, Skeletal; Myocardial Ischemia; Myocardium; NAD; NADP; Nanocomposites; Nanoparticles; Naphthols; Nasal Lavage Fluid; Nasal Mucosa; Neisseria meningitidis; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasms, Experimental; Neural Stem Cells; Neuroblastoma; Neurofilament Proteins; Neurogenesis; Neurons; New York; NF-E2-Related Factor 2; NF-kappa B; Nicotine; Nitriles; Nitrogen; Nitrogen Fixation; North America; Observer Variation; Occupational Exposure; Ochrobactrum; Oils, Volatile; Olea; Oligosaccharides; Omeprazole; Open Field Test; Optimism; Oregon; Oryzias; Osmolar Concentration; Osteoarthritis; Osteoblasts; Osteogenesis; Ovarian Neoplasms; Ovariectomy; Oxadiazoles; Oxidation-Reduction; Oxidative Stress; Oxygen; Ozone; p38 Mitogen-Activated Protein Kinases; Pakistan; Pandemics; Particle Size; Particulate Matter; Patient-Centered Care; Pelargonium; Peptides; Perception; Peripheral Arterial Disease; Peroxides; Pets; Pharmaceutical Preparations; Pharmacogenetics; Phenobarbital; Phenols; Phenotype; Phosphates; Phosphatidylethanolamines; Phosphines; Phospholipids; Phosphorus; Phosphorylation; Photoacoustic Techniques; Photochemotherapy; Photosensitizing Agents; Phylogeny; Phytoestrogens; Pilot Projects; Plant Components, Aerial; Plant Extracts; Plant Immunity; Plant Leaves; Plant Oils; Plants, Medicinal; Plasmodium berghei; Plasmodium falciparum; Platelet Activation; Platelet Function Tests; Pneumonia, Viral; Poaceae; Pogostemon; Poloxamer; Poly I; Poly(ADP-ribose) Polymerase Inhibitors; Polychlorinated Biphenyls; Polychlorinated Dibenzodioxins; Polycyclic Compounds; Polyethylene Glycols; Polylysine; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Population Dynamics; Portasystemic Shunt, Transjugular Intrahepatic; Positron Emission Tomography Computed Tomography; Postoperative Complications; Postprandial Period; Potassium Cyanide; Predictive Value of Tests; Prefrontal Cortex; Pregnancy; Prepulse Inhibition; Prevalence; Procalcitonin; Prodrugs; Prognosis; Progression-Free Survival; Proline; Proof of Concept Study; Prospective Studies; Protein Binding; Protein Conformation; Protein Domains; Protein Folding; Protein Multimerization; Protein Sorting Signals; Protein Structure, Secondary; Proton Pump Inhibitors; Protozoan Proteins; Psychometrics; Pulse Wave Analysis; Pyridines; Pyrrolidines; Quality of Life; Quantum Dots; Quinoxalines; Quorum Sensing; Radiopharmaceuticals; Rain; Random Allocation; Randomized Controlled Trials as Topic; Rats; Rats, Sprague-Dawley; Rats, Wistar; RAW 264.7 Cells; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Receptor, PAR-1; Receptors, CXCR4; Receptors, Estrogen; Receptors, Glucocorticoid; Receptors, Interleukin-1; Receptors, Interleukin-17; Receptors, Notch; Recombinant Fusion Proteins; Recombinant Proteins; Reducing Agents; Reflex, Startle; Regional Blood Flow; Regression Analysis; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Tract Diseases; Retrospective Studies; Reverse Transcriptase Inhibitors; Rhinitis, Allergic; Risk Assessment; Risk Factors; Rituximab; RNA, Messenger; RNA, Ribosomal, 16S; ROC Curve; Rosmarinic Acid; Running; Ruthenium; Rutin; Sarcolemma; Sarcoma; Sarcopenia; Sarcoplasmic Reticulum; SARS-CoV-2; Scavenger Receptors, Class A; Schools; Seasons; Seeds; Sequence Analysis, DNA; Severity of Illness Index; Sex Factors; Shock, Cardiogenic; Short Chain Dehydrogenase-Reductases; Signal Transduction; Silver; Singlet Oxygen; Sinusitis; Skin; Skin Absorption; Small Molecule Libraries; Smoke; Socioeconomic Factors; Soil; Soil Microbiology; Solid Phase Extraction; Solubility; Solvents; Spain; Spectrometry, Mass, Electrospray Ionization; Spectroscopy, Fourier Transform Infrared; Speech; Speech Perception; Spindle Poles; Spleen; Sporothrix; Staphylococcal Infections; Staphylococcus aureus; Stereoisomerism; Stomach Neoplasms; Stress, Physiological; Stroke Volume; Structure-Activity Relationship; Substrate Specificity; Sulfonamides; Surface Properties; Surface-Active Agents; Surveys and Questionnaires; Survival Rate; T-Lymphocytes, Cytotoxic; Tandem Mass Spectrometry; Temperature; Tenofovir; Terpenes; Tetracycline; Tetrapleura; Textiles; Thermodynamics; Thiobarbituric Acid Reactive Substances; Thrombin; Thyroid Hormones; Thyroid Neoplasms; Tibial Meniscus Injuries; Time Factors; Tissue Distribution; Titanium; Toluidines; Tomography, X-Ray Computed; Tooth; Tramadol; Transcription Factor AP-1; Transcription, Genetic; Transfection; Transgender Persons; Translations; Treatment Outcome; Triglycerides; Ubiquinone; Ubiquitin-Specific Proteases; United Kingdom; United States; Up-Regulation; Vascular Stiffness; Veins; Ventricular Remodeling; Viral Load; Virulence Factors; Virus Replication; Vitis; Voice; Voice Quality; Wastewater; Water; Water Pollutants, Chemical; Water-Electrolyte Balance; Weather; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Young Adult; Zoogloea | 2022 |
Predicting the probability of abnormal stimulated growth hormone response in children after radiotherapy for brain tumors.
Topics: Adolescent; Arginine; Biomarkers; Brain Neoplasms; Child; Child, Preschool; Craniopharyngioma; Ependymoma; Feasibility Studies; Female; Glioma; Human Growth Hormone; Humans; Hypothalamus; Infant; Insulin-Like Growth Factor Binding Protein 3; Insulin-Like Growth Factor I; Levodopa; Logistic Models; Male; Models, Biological; Predictive Value of Tests; Probability; Prospective Studies; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Conformal; ROC Curve; Sensitivity and Specificity | 2012 |
[Comparison of two regimens of postoperative concurrent chemoradiotherapy in adult patients with grade III-IV cerebral gliomas].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Chemoradiotherapy; Dacarbazine; Female; Glioma; Humans; Male; Middle Aged; Postoperative Period; Semustine; Temozolomide; Teniposide; Young Adult | 2012 |
Neuro-Oncology Working Group 01 trial of nimustine plus teniposide versus nimustine plus cytarabine chemotherapy in addition to involved-field radiotherapy in the first-line treatment of malignant glioma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Disease Progression; Female; Glioblastoma; Glioma; Humans; Male; Middle Aged; Nimustine; Prognosis; Prospective Studies; Survival Analysis; Teniposide; Treatment Outcome | 2003 |
Carboplatin and teniposide as third-line chemotherapy in patients with recurrent oligodendroglioma or oligoastrocytoma: a phase II study.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Carboplatin; Combined Modality Therapy; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Neoplasm Recurrence, Local; Neutropenia; Oligodendroglioma; Survival Analysis; Teniposide; Thrombocytopenia; Treatment Outcome | 2003 |
[Sequential treatment of VmP regimen and whole brain radiotherapy for small cell lung cancer patients with brain metastases].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Female; Follow-Up Studies; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Prospective Studies; Survival Rate; Teniposide | 2004 |
Clinical trial of CPT-11 and VM-26/VP-16 for patients with recurrent malignant brain tumors.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Camptothecin; Etoposide; Female; Glioma; Humans; Irinotecan; Magnetic Resonance Imaging; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Recurrence, Local; Teniposide; Tomography, X-Ray Computed | 2007 |
Adjuvant chemotherapy with VM 26 and CCNU after operation and radiotherapy of high-grade supratentorial astrocytomas.
Topics: Adult; Aged; Brain Neoplasms; Drug Therapy, Combination; Female; Glioblastoma; Humans; Lomustine; Male; Middle Aged; Nitrosourea Compounds; Podophyllotoxin; Teniposide | 1980 |
Teniposide: a review of 12 years of experience.
Topics: Adult; Animals; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cell Cycle; Cell Line; Child; Clinical Trials as Topic; Colonic Neoplasms; DNA, Neoplasm; Drug Evaluation, Preclinical; Drug Resistance; Humans; Leukemia; Lymphoma; Mice; Neoplasms; Neoplasms, Experimental; Neuroblastoma; Podophyllotoxin; Teniposide | 1984 |
Intracarotid chemotherapy with a combination of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU), cis-diaminedichloroplatinum (cisplatin), and 4'-O-demethyl-1-O-(4,6-O-2-thenylidene-beta-D-glucopyranosyl) epipodophyllotoxin (VM-26) in the treatment of primary
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carmustine; Carotid Arteries; Cisplatin; Clinical Trials as Topic; Combined Modality Therapy; Ependymoma; Female; Glioma; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Oligodendroglioma; Teniposide; Tomography, X-Ray Computed | 1984 |
Evaluation of CCNU, VM-26 plus CCNU, and procarbazine in supratentorial brain gliomas. Final evaluation of a randomized study. European Organization for Research on Treatment of Cancer (EORTC) Brain Tumor Group.
Topics: Antineoplastic Agents; Brain Neoplasms; Clinical Trials as Topic; Drug Therapy, Combination; Female; Glioma; Humans; Lomustine; Male; Procarbazine; Prospective Studies; Random Allocation; Teniposide | 1981 |
A review of studies of the EORTC brain tumor group.
Topics: Antineoplastic Agents; Brain Neoplasms; Clinical Trials as Topic; Dexamethasone; Drug Administration Schedule; Drug Therapy, Combination; Follow-Up Studies; Humans; Lomustine; Middle Aged; Procarbazine; Teniposide | 1981 |
[VM-26 plus CCNU in the prevention of brain metastasis in lung cancer patients].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carcinoma, Squamous Cell; Female; Humans; Lomustine; Lung Neoplasms; Male; Middle Aged; Teniposide | 1995 |
Teniposide for brain metastases of small-cell lung cancer: a phase II study. European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group.
Topics: Adult; Aged; Brain Neoplasms; Carcinoma, Small Cell; Cranial Irradiation; Europe; Female; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Multivariate Analysis; Proportional Hazards Models; Remission Induction; Teniposide; Thrombocytopenia; Tomography, X-Ray Computed | 1995 |
Feasibility study of intraarterial vs intravenous cisplatin, BCNU, and teniposide combined with systemic cisplatin, teniposide, cytosine arabinoside, glycerol and mannitol in the treatment of primary and metastatic brain tumors.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carmustine; Cisplatin; Cytarabine; Female; Glioma; Glycerol; Humans; Infusions, Intra-Arterial; Infusions, Intravenous; Male; Mannitol; Middle Aged; Survival Rate; Teniposide | 1993 |
Early chemotherapy and concurrent radio-chemotherapy in high grade glioma.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Carmustine; Combined Modality Therapy; Female; Glioblastoma; Humans; Male; Middle Aged; Survival Analysis; Teniposide; Time Factors | 1996 |
Carboplatin and teniposide concurrent with radiotherapy in patients with glioblastoma multiforme: a phase II study.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Carmustine; Combined Modality Therapy; Disease Progression; Female; Glioblastoma; Humans; Male; Middle Aged; Multivariate Analysis; Necrosis; Nitrosourea Compounds; Proportional Hazards Models; Radiation Injuries; Radiotherapy Dosage; Survival Analysis; Survival Rate; Teniposide; Thrombocytopenia; Treatment Outcome | 1998 |
Chemotherapy with cisplatin and teniposide for cerebral metastases in non-small cell lung cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carcinoma, Non-Small-Cell Lung; Cisplatin; Humans; Lung Neoplasms; Male; Middle Aged; Survival Rate; Teniposide; Tomography, X-Ray Computed; Treatment Outcome | 1998 |
Teniposide sometimes effective in brain metastases from non-small cell lung cancer.
Topics: Aged; Antineoplastic Agents; Brain Neoplasms; Carcinoma, Non-Small-Cell Lung; Disease Progression; Female; Humans; Lung Neoplasms; Male; Middle Aged; Prospective Studies; Radiography; Teniposide; Tomography, Emission-Computed; Treatment Outcome | 1999 |
Treatment of brain metastases of small-cell lung cancer: comparing teniposide and teniposide with whole-brain radiotherapy--a phase III study of the European Organization for the Research and Treatment of Cancer Lung Cancer Cooperative Group.
Topics: Adult; Aged; Analysis of Variance; Antineoplastic Agents; Brain Neoplasms; Carcinoma, Small Cell; Combined Modality Therapy; Cranial Irradiation; Disease-Free Survival; Female; Humans; Lung Neoplasms; Male; Middle Aged; Teniposide | 2000 |
Enhancement of bone marrow toxicity of VM-26-CCNU combination by bleomycin.
Topics: Adult; Aged; Bleomycin; Bone Marrow; Brain Neoplasms; Clinical Trials as Topic; Drug Therapy, Combination; Female; Humans; Leukopenia; Lomustine; Male; Middle Aged; Nitrosourea Compounds; Podophyllotoxin; Teniposide | 1977 |
Treatment of malignant gliomas and brain metastases in adults using a combination of adriamycine, VM 26, and CCNU. Results of a type II trial.
Topics: Adult; Aged; Brain Neoplasms; Breast Neoplasms; Clinical Trials as Topic; Doxorubicin; Drug Therapy, Combination; Evaluation Studies as Topic; Female; Glioma; Humans; Lomustine; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Nitrosourea Compounds; Podophyllotoxin; Teniposide | 1977 |
[A study of the use of sequential chemotherapy in 176 cases of glioblastoma (author's transl)].
Topics: Adult; Brain Neoplasms; Clinical Trials as Topic; Doxorubicin; Drug Therapy, Combination; Follow-Up Studies; Glioma; Humans; Lomustine; Nitrosourea Compounds; Podophyllotoxin; Procarbazine; Random Allocation; Remission, Spontaneous; Teniposide; Time Factors | 1978 |
Nonresponsiveness of brain tumors to VM-26 therapy in children.
Topics: Adolescent; Brain Neoplasms; Child; Child, Preschool; Clinical Trials as Topic; Humans; Podophyllotoxin; Teniposide; Time Factors | 1979 |
[Surgically treated supratentorial gliomas in the adult. Favourable action of a podophyllin derivative (VM 26) administered alone (author's transl)].
Topics: Brain Neoplasms; Drug Tolerance; Glioma; Humans; Podophyllotoxin; Teniposide | 1978 |
[Letter: Chemotherapy of operated malignant brain gliomas using a combination of VM 26 and CCNU].
Topics: Brain Neoplasms; Clinical Trials as Topic; Drug Therapy, Combination; Follow-Up Studies; Glioma; Humans; Lomustine; Nitrosourea Compounds; Podophyllotoxin; Teniposide | 1976 |
[Trial treatment of glioblastomas in adults and cerebral metastais by adriamycin, VM 26 and CCNU combination. Result of a type II trial].
Topics: Adult; Aged; Brain Neoplasms; Clinical Trials as Topic; Doxorubicin; Drug Evaluation; Drug Therapy, Combination; Female; Glioma; Humans; Lomustine; Male; Middle Aged; Neoplasm Metastasis; Nitrosourea Compounds; Podophyllotoxin; Remission, Spontaneous; Teniposide | 1976 |
Advantage of post-radiotherapy chemotherapy with CCNU, procarbazine, and vincristine (mPCV) over chemotherapy with VM-26 and CCNU for malignant gliomas.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Combined Modality Therapy; Female; Glioblastoma; Glioma; Humans; Lomustine; Male; Middle Aged; Procarbazine; Teniposide; Vincristine | 1992 |
[Chemotherapy of malignant glioma. Results of studies of the EORTC group of brain tumors].
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cisplatin; Combined Modality Therapy; Glioma; Humans; Lomustine; Supratentorial Neoplasms; Survival Analysis; Teniposide | 1992 |
Treatment of relapsed acute lymphocytic leukemia in adults.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Transplantation; Brain Neoplasms; Combined Modality Therapy; Cytarabine; Daunorubicin; Dexamethasone; Etoposide; Female; Germany, West; Humans; Ifosfamide; Leucovorin; Life Tables; Male; Methotrexate; Middle Aged; Multicenter Studies as Topic; Neoplasm Recurrence, Local; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Spinal Cord Neoplasms; Teniposide; Testicular Neoplasms; Vindesine | 1990 |
Randomized phase III trial of single versus multiple chemotherapeutic treatment following surgery and during radiotherapy for patients with anaplastic gliomas.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carmustine; Clinical Trials as Topic; Combined Modality Therapy; Glioma; Humans; Hydroxyurea; Methylprednisolone; Middle Aged; Mitolactol; Procarbazine; Random Allocation; Teniposide; Tomography, X-Ray Computed | 1987 |
131 other study(ies) available for arginine and Brain Neoplasms
| Article | Year |
|---|---|
Characterisation of Expression the Arginine Pathway Enzymes in Childhood Brain Tumours to Determine Susceptibility to Therapeutic Arginine Depletion.
Topics: Adult; Arginase; Arginine; Argininosuccinate Lyase; Brain Neoplasms; Cerebellar Neoplasms; Child; Ependymoma; Glioma; Humans; Medulloblastoma; Ornithine Carbamoyltransferase | 2022 |
Accelerated and quantitative three-dimensional molecular MRI using a generative adversarial network.
Topics: Arginine; Brain; Brain Neoplasms; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy | 2023 |
Investigating the effects of arginine methylation inhibitors on microdissected brain tumour biopsies maintained in a miniaturised perfusion system.
Topics: Arginine; Brain Neoplasms; Humans; Methylation; Perfusion; Protein Processing, Post-Translational; Quality of Life | 2023 |
Both p53 codon 72 Arg/Arg and pro/Arg genotypes in glioblastoma multiforme are associated with a better prognosis in bevacizumab treatment.
Topics: Angiogenesis Inhibitors; Antineoplastic Agents, Immunological; Arginine; Bevacizumab; Brain Neoplasms; Codon; Female; Gene Amplification; Genes, p53; Genotype; Glioblastoma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Pilot Projects; Polymorphism, Genetic; Prognosis; Proline; Retrospective Studies; Sequence Analysis, DNA; Taiwan; Treatment Outcome | 2020 |
Identification of metabolites in plasma for predicting survival in glioblastoma.
Topics: Adult; Arginine; Biomarkers, Tumor; Brain Neoplasms; Disease-Free Survival; Female; Glioblastoma; Humans; Kynurenic Acid; Male; Metabolome; Metabolomics; Methionine; Middle Aged; Prognosis; Proportional Hazards Models | 2018 |
IDH1 Arg-132 mutant promotes tumor formation through down-regulating p53.
Topics: Animals; Arginine; Brain Neoplasms; Carcinogenesis; Cell Proliferation; Gene Expression Regulation, Neoplastic; Glioma; Glutarates; Humans; Isocitrate Dehydrogenase; Mice; MicroRNAs; Mutation; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays | 2018 |
Combined Diffuse Astrocytoma and Pleomorphic Xanthoastrocytoma Grade III Sharing IDH1 R132H Mutation.
Topics: Arginine; Astrocytoma; Brain Neoplasms; Histidine; Humans; Isocitrate Dehydrogenase; Magnetic Resonance Imaging; Mutation | 2018 |
Inhibition of a K9/K36 demethylase by an H3.3 point mutation found in paediatric glioblastoma.
Topics: Animals; Arginine; Biotinylation; Brain Neoplasms; Child; Chromatin; Disease Models, Animal; Embryonic Stem Cells; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Glioblastoma; Glycine; Histones; Humans; Mice; Mutation; Point Mutation; Protein Binding; Sequence Analysis, RNA; Transgenes | 2018 |
PRMT2 links histone H3R8 asymmetric dimethylation to oncogenic activation and tumorigenesis of glioblastoma.
Topics: Arginine; Brain Neoplasms; Carcinogenesis; Cell Line, Tumor; Cell Proliferation; Cell Self Renewal; Enhancer Elements, Genetic; Gene Expression Regulation, Neoplastic; Glioblastoma; Histones; Humans; Intracellular Signaling Peptides and Proteins; Methylation; Oncogenes; Promoter Regions, Genetic; Protein-Arginine N-Methyltransferases; Transcription, Genetic | 2018 |
Efficacy of arginine depletion by ADI-PEG20 in an intracranial model of GBM.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Arginine; Argininosuccinate Synthase; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Glioblastoma; Humans; Hydrolases; Mice; Polyethylene Glycols; Temozolomide; Xenograft Model Antitumor Assays | 2018 |
L-cysteine and poly-L-arginine grafted carboxymethyl cellulose/Ag-In-S quantum dot fluorescent nanohybrids for in vitro bioimaging of brain cancer cells.
Topics: Arginine; Biological Transport; Brain Neoplasms; Carboxymethylcellulose Sodium; Cell Line, Tumor; Cell Survival; Chemical Phenomena; Cysteine; Fluorescent Dyes; Humans; Microscopy, Confocal; Nanocomposites; Quantum Dots | 2019 |
Lack of B and T cell reactivity towards IDH1
Topics: Arginine; B-Lymphocytes; Brain Neoplasms; Glioma; Humans; Isocitrate Dehydrogenase; Mutation; Prognosis; T-Lymphocytes | 2019 |
Nonviral gene therapy in vivo with PAM-RG4/apoptin as a potential brain tumor therapeutic.
Topics: Animals; Antineoplastic Agents; Apoptosis; Arginine; Brain Neoplasms; Capsid Proteins; Cell Line, Tumor; Cell Survival; Dendrimers; Genetic Therapy; Humans; In Situ Nick-End Labeling; Mice; Mice, Nude; Random Allocation; Reverse Transcriptase Polymerase Chain Reaction; Transfection; Xenograft Model Antitumor Assays | 2013 |
Sox11 expression in astrocytic gliomas: correlation with nestin/c-Met/IDH1-R132H expression phenotypes, p-Stat-3 and survival.
Topics: Adult; Aged; Aged, 80 and over; Amino Acid Substitution; Arginine; Astrocytoma; Biomarkers, Tumor; Brain Neoplasms; Cohort Studies; Female; Gene Expression Regulation, Neoplastic; Histidine; Humans; Intermediate Filament Proteins; Isocitrate Dehydrogenase; Male; Middle Aged; Nerve Tissue Proteins; Nestin; Phenotype; Phosphorylation; Prognosis; Protein Kinases; Proto-Oncogene Proteins c-met; SOXC Transcription Factors; STAT3 Transcription Factor; Survival Analysis; Tumor Cells, Cultured; Young Adult | 2013 |
Establishment of a multi-specific monoclonal antibody MsMab-1 recognizing both IDH1 and IDH2 mutations.
Topics: Amino Acids; Animals; Antibodies, Monoclonal; Arginine; Brain Neoplasms; CHO Cells; Codon; Cricetulus; Enzyme-Linked Immunosorbent Assay; Glioma; Humans; Immunohistochemistry; Isocitrate Dehydrogenase; Mice; Mutation; Peptides; Recombinant Proteins | 2013 |
Expression of PRMT5 correlates with malignant grade in gliomas and plays a pivotal role in tumor growth in vitro.
Topics: Adult; Aged; Arginine; Brain Neoplasms; Cell Differentiation; Cell Proliferation; Colonic Neoplasms; Colony-Forming Units Assay; Epithelium; Female; Glial Fibrillary Acidic Protein; Glioma; Humans; Male; MAP Kinase Signaling System; Middle Aged; Neurons; Phosphopyruvate Hydratase; Protein-Arginine N-Methyltransferases; RNA, Small Interfering | 2014 |
Modulation of uPA, MMPs and their inhibitors by a novel nutrient mixture in human glioblastoma cell lines.
Topics: Arginine; Ascorbic Acid; Brain Neoplasms; Camellia sinensis; Cell Line, Tumor; Copper; Electrophoresis, Polyacrylamide Gel; Gene Expression Regulation, Neoplastic; Glioblastoma; Humans; Lysine; Manganese; Matrix Metalloproteinases; Micronutrients; Plant Extracts; Proline; Selenium; Tissue Inhibitor of Metalloproteinases; Urokinase-Type Plasminogen Activator | 2014 |
IDH1 mutation is associated with seizures and protoplasmic subtype in patients with low-grade gliomas.
Topics: Adolescent; Adult; Aged; Arginine; Astrocytoma; Brain Neoplasms; Cohort Studies; Epilepsy; Female; Genetic Association Studies; Histidine; Humans; Isocitrate Dehydrogenase; Male; Middle Aged; Mutation; Seizures; Young Adult | 2014 |
Arginine deprivation affects glioblastoma cell adhesion, invasiveness and actin cytoskeleton organization by impairment of β-actin arginylation.
Topics: Actin Cytoskeleton; Actins; Arginine; Brain Neoplasms; Cell Adhesion; Cell Line, Tumor; Cytoskeleton; Glioblastoma; Humans; Neoplasm Invasiveness | 2015 |
Tumor-specific delivery of BSH-3R for boron neutron capture therapy and positron emission tomography imaging in a mouse brain tumor model.
Topics: Animals; Arginine; Boron; Boron Neutron Capture Therapy; Boronic Acids; Brain Neoplasms; Cell Line, Tumor; Cell Survival; Copper; Disease Models, Animal; Drug Delivery Systems; Female; Glioma; Heterocyclic Compounds, 1-Ring; Humans; Immunohistochemistry; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Oligopeptides; Peptides; Positron-Emission Tomography; Tomography, X-Ray Computed | 2015 |
Reducible Poly(Oligo-D-Arginine) as an Efficient Carrier of the Thymidine Kinase Gene in the Intracranial Glioblastoma Animal Model.
Topics: Animals; Arginine; Brain; Brain Neoplasms; Cell Line, Tumor; Gene Transfer Techniques; Genes, Reporter; Genetic Therapy; Genetic Vectors; Glioblastoma; Humans; Oxidation-Reduction; Rats; Thymidine Kinase | 2015 |
Reducible Micelleplexes are Stable Systems for Anti-miRNA Delivery in Cerebrospinal Fluid.
Topics: Antineoplastic Agents; Arginine; Brain Neoplasms; Cerebrospinal Fluid; Drug Delivery Systems; Glioblastoma; Humans; Micelles; MicroRNAs; Nanoparticles; Polyesters; Polyethylene Glycols; Polymers | 2016 |
Low expressions of ASS1 and OTC in glioblastoma suggest the potential clinical use of recombinant human arginase (rhArg).
Topics: Adolescent; Adult; Aged; Arginine; Argininosuccinate Lyase; Argininosuccinate Synthase; Biomarkers, Tumor; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Child; Child, Preschool; Glioblastoma; Humans; Middle Aged; Ornithine Carbamoyltransferase; Polyethylene Glycols; Prognosis; Recombinant Proteins; Survival Rate; Young Adult | 2016 |
Protein arginine methyltransferase 1 is a novel regulator of MYCN in neuroblastoma.
Topics: Arginine; Brain Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Mutation; N-Myc Proto-Oncogene Protein; Neuroblastoma; Phosphorylation; Prognosis; Proportional Hazards Models; Protein Processing, Post-Translational; Protein-Arginine N-Methyltransferases; Repressor Proteins; RNA, Small Interfering; Threonine | 2016 |
In Silico prediction of the molecular basis of ClTx and AaCTx interaction with matrix metalloproteinase-2 (MMP-2) to inhibit glioma cell invasion.
Topics: Arginine; Binding Sites; Brain Neoplasms; Cell Line, Tumor; Computer Simulation; Glioma; Humans; Matrix Metalloproteinase 2; Molecular Dynamics Simulation; Neoplasm Invasiveness; Peptides; Protein Binding; Scorpion Venoms | 2017 |
Apoptin Gene Delivery by the Functionalized Polyamidoamine Dendrimer Derivatives Induces Cell Death of U87-MG Glioblastoma Cells.
Topics: Apoptosis; Arginine; Brain Neoplasms; Capsid Proteins; Cell Line, Tumor; Cells, Cultured; Dendrimers; DNA; Genetic Therapy; Glioblastoma; Histidine; Humans; Lysine; Transfection | 2017 |
Increase in brain tumor permeability in glioma-bearing rats with nitric oxide donors.
Topics: Administration, Oral; Animals; Arginine; Blood-Brain Barrier; Brain Neoplasms; Capillary Permeability; Citrulline; Cyclic GMP; Drug Delivery Systems; Drug Evaluation, Preclinical; Drug Synergism; Female; Glioma; Hydroxyurea; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase; Rats; Rats, Inbred F344; Tumor Cells, Cultured | 2008 |
Neuropeptide Y receptors in primary human brain tumors: overexpression in high-grade tumors.
Topics: Arginine; Autoradiography; Benzazepines; Binding, Competitive; Brain Neoplasms; Dose-Response Relationship, Drug; Guanosine 5'-O-(3-Thiotriphosphate); Humans; Iodine Radioisotopes; Peptides; Protein Binding; Receptors, Neuropeptide Y; Tissue Distribution | 2008 |
Cranially irradiated adult cancer survivors may have normal spontaneous GH secretion in the presence of discordant peak GH responses to stimulation tests (compensated GH deficiency).
Topics: Adolescent; Adult; Arginine; Brain Neoplasms; Case-Control Studies; Female; Follow-Up Studies; Growth Hormone-Releasing Hormone; Human Growth Hormone; Humans; Hypothalamo-Hypophyseal System; Insulin; Insulin-Like Growth Factor I; Leukemia; Lymphoma; Male; Middle Aged; Radiotherapy; Young Adult | 2009 |
Cancer. Puzzling patterns of predisposition.
Topics: Amino Acid Substitution; Arginine; Brain Neoplasms; Citric Acid Cycle; Dinucleoside Phosphates; Fumarate Hydratase; Genes, Tumor Suppressor; Genetic Predisposition to Disease; Glioblastoma; Glutamates; Humans; Hydroxylation; Hypoxia-Inducible Factor 1; Isocitrate Dehydrogenase; Mutation; NADP; Oncogenes; Succinate Dehydrogenase | 2009 |
Thrombin enhances glioma growth.
Topics: Animals; Anticoagulants; Arginine; Behavior, Animal; Brain Neoplasms; Bromodeoxyuridine; Cell Line, Tumor; Cell Proliferation; Enzyme-Linked Immunosorbent Assay; Functional Laterality; Glioma; Hemostatics; Male; Neoplasm Transplantation; Pipecolic Acids; Rats; Rats, Inbred F344; Sulfonamides; Tetrazolium Salts; Thiazoles; Thrombin; Time Factors | 2008 |
Monoclonal antibody specific for IDH1 R132H mutation.
Topics: Animals; Antibodies, Monoclonal; Arginine; Astrocytoma; Brain Neoplasms; Histidine; Humans; Isocitrate Dehydrogenase; Mice; Mutant Proteins; Mutation; Oligodendroglioma; Sensitivity and Specificity | 2009 |
Cancer-associated IDH1 mutations produce 2-hydroxyglutarate.
Topics: Arginine; Brain Neoplasms; Catalytic Domain; Cell Line; Crystallography, X-Ray; Disease Progression; Enzyme Assays; Glioma; Glutarates; Histidine; Humans; Isocitrate Dehydrogenase; Ketoglutaric Acids; Models, Molecular; Mutant Proteins; Mutation; Protein Conformation | 2009 |
Detection of IDH1 mutations in gliomatosis cerebri, but only in tumors with additional solid component: evidence for molecular subtypes.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Arginine; Astrocytoma; Brain Neoplasms; Chromosomes, Human, Pair 1; Chromosomes, Human, Pair 19; DNA Mutational Analysis; Female; Histidine; Humans; In Situ Hybridization, Fluorescence; Isocitrate Dehydrogenase; Magnetic Resonance Imaging; Male; Middle Aged; Mutation; Neoplasms, Neuroepithelial; Oligodendroglioma; Polymorphism, Single Nucleotide; Tumor Suppressor Protein p53 | 2010 |
Enhancement of the citrulline-nitric oxide cycle in astroglioma cells by the proline-rich peptide-10c from Bothrops jararaca venom.
Topics: Animals; Arginine; Argininosuccinate Lyase; Argininosuccinate Synthase; Astrocytoma; Brain Neoplasms; Cell Division; Cell Line, Tumor; Citrulline; Crotalid Venoms; Dose-Response Relationship, Drug; Drug Design; Neuroglia; Nitric Oxide; Proline-Rich Protein Domains; Rats; Up-Regulation | 2010 |
Mutation-specific IDH1 antibody differentiates oligodendrogliomas and oligoastrocytomas from other brain tumors with oligodendroglioma-like morphology.
Topics: Adolescent; Adult; Aged; Antibodies; Arginine; Astrocytoma; Brain Neoplasms; Child; Child, Preschool; Chromosomes, Human, Pair 1; Chromosomes, Human, Pair 19; Female; Glioma; Histidine; Humans; Isocitrate Dehydrogenase; Male; Middle Aged; Mutation; Nerve Tissue Proteins; Oligodendroglioma; Young Adult | 2011 |
Chemical re-engineering of chlorotoxin improves bioconjugation properties for tumor imaging and targeted therapy.
Topics: Alanine; Amino Acid Sequence; Amino Acid Substitution; Animals; Arginine; Brain Neoplasms; Carbocyanines; Fluorescent Dyes; Half-Life; Lysine; Medulloblastoma; Mice; Mice, Inbred C57BL; Models, Molecular; Molecular Sequence Data; Peptides; Peptides, Cyclic; Scorpion Venoms | 2011 |
Analysis of the polymorphisms XRCC1Arg194Trp and XRCC1Arg399Gln in gliomas.
Topics: Arginine; Brain Neoplasms; DNA Primers; DNA-Binding Proteins; Glioma; Glycine; Humans; Polymerase Chain Reaction; Polymorphism, Single Nucleotide; Tryptophan; X-ray Repair Cross Complementing Protein 1 | 2011 |
Value and limitations of immunohistochemistry and gene sequencing for detection of the IDH1-R132H mutation in diffuse glioma biopsy specimens.
Topics: Arginine; Biopsy; Brain Neoplasms; Genetic Testing; Glioma; Histidine; Humans; Immunohistochemistry; Isocitrate Dehydrogenase; Mutation; Reproducibility of Results; Sequence Analysis | 2011 |
Neutrophil degranulation and immunosuppression in patients with GBM: restoration of cellular immune function by targeting arginase I.
Topics: Arginase; Arginine; Brain Neoplasms; Cell Degranulation; Cells, Cultured; Glioblastoma; Humans; Immune Tolerance; Immunity, Cellular; Molecular Targeted Therapy; Neutrophils; T-Lymphocytes | 2011 |
Glioma derived isocitrate dehydrogenase-2 mutations induced up-regulation of HIF-1α and β-catenin signaling: possible impact on glioma cell metastasis and chemo-resistance.
Topics: Animals; Arginine; beta Catenin; Brain Neoplasms; Cell Line, Tumor; Disease Progression; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Glioma; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Isocitrate Dehydrogenase; Isoenzymes; Mutation; Neoplasm Invasiveness; Rats; Signal Transduction; Transfection; Up-Regulation | 2012 |
Arginine modified PAMAM dendrimer for interferon beta gene delivery to malignant glioma.
Topics: Animals; Apoptosis; Arginine; Brain Neoplasms; Caspase 3; Cell Line; Cell Line, Tumor; Dendrimers; Gene Transfer Techniques; Genetic Therapy; Glioma; Humans; Interferon-beta; Mice; Mice, Nude; Tumor Burden; Xenograft Model Antitumor Assays | 2013 |
A thrombin inhibitor reduces brain edema, glioma mass and neurological deficits in a rat glioma model.
Topics: Animals; Antithrombins; Arginine; Brain Edema; Brain Neoplasms; Cell Line, Tumor; Glioma; Immunohistochemistry; Nervous System Diseases; Pipecolic Acids; Rats; Rats, Inbred F344; Sulfonamides; Thrombin | 2003 |
Assessment of tumor cell invasion factors in gliomatosis cerebri.
Topics: Adolescent; Adult; Aged; Alleles; Arginine; Brain Neoplasms; Female; Humans; Hyaluronan Receptors; Immunohistochemistry; Male; Matrix Metalloproteinase 9; Middle Aged; Neoplasm Invasiveness; Neoplasms, Neuroepithelial; Receptor, Fibroblast Growth Factor, Type 4; Receptors, Fibroblast Growth Factor; Severity of Illness Index; Tenascin | 2005 |
Systemic use of argatroban reduces tumor mass, attenuates neurological deficits and prolongs survival time in rat glioma models.
Topics: Animals; Anticoagulants; Antineoplastic Agents; Arginine; Brain; Brain Edema; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Glioma; Injections, Intraventricular; Male; Mental Disorders; Pipecolic Acids; Rats; Rats, Inbred F344; Sulfonamides; Survival Rate; Treatment Outcome | 2005 |
Hypopituitarism findings in patients with primary brain tumors 1 year after neurosurgical treatment: preliminary report.
Topics: Adult; Aged; Arginine; Brain Neoplasms; Estradiol; Female; Follicle Stimulating Hormone; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Hydrocortisone; Hypopituitarism; Luteinizing Hormone; Male; Middle Aged; Neurosurgical Procedures; Pituitary Function Tests; Postoperative Complications; Prospective Studies; Somatomedins; Testosterone; Thyrotropin; Thyroxine | 2006 |
Cranial irradiation and growth hormone neurosecretory dysfunction: a critical appraisal.
Topics: Adolescent; Adrenal Cortex Function Tests; Adrenocorticotropic Hormone; Adult; Arginine; Brain Neoplasms; Cluster Analysis; Fasting; Female; Glucose Tolerance Test; Human Growth Hormone; Humans; Hypothalamo-Hypophyseal System; Leukemia; Male; Middle Aged; Pituitary Diseases; Radiotherapy; Sex Characteristics; Survivors | 2007 |
TP53 codon 72 polymorphism in susceptibility, overall survival, and adjuvant therapy response of gliomas.
Topics: Adult; Arginine; Brain Neoplasms; Case-Control Studies; Codon; Combined Modality Therapy; Female; Gene Frequency; Genes, p53; Genetic Predisposition to Disease; Glioma; Humans; Male; Middle Aged; Polymorphism, Genetic; Proline; Retrospective Studies; Survival Rate; Treatment Outcome | 2008 |
Effect of arginine salt of thioproline (thiazolidine carboxylate) on cyclic nucleotides of cerebral tumour.
Topics: Arginine; Brain Chemistry; Brain Neoplasms; Cyclic AMP; Cyclic GMP; Humans; Thiazoles; Thiazolidines | 1980 |
Hypothalamic growth hormone releasing factor deficiency following cranial irradiation.
Topics: Adolescent; Adult; Arginine; Brain Neoplasms; Child; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Hypothalamo-Hypophyseal System; Insulin; Male; Pancreatic Hormones; Peptide Fragments; Radiotherapy | 1984 |
Inhibition of neuronal nitric oxide synthase by antipsychotic drugs.
Topics: Amino Acid Oxidoreductases; Animals; Antipsychotic Agents; Arginine; Brain Neoplasms; Calmodulin; Cerebellum; Citrulline; Cyclic GMP; Cytosol; In Vitro Techniques; Male; Mice; Neuroblastoma; Neurons; Nitric Oxide Synthase; Phosphodiesterase Inhibitors; Rats; Rats, Sprague-Dawley; Tumor Cells, Cultured | 1994 |
Mutant IGF-I receptors as dominant negatives for growth and transformation.
Topics: Analysis of Variance; Animals; Apoptosis; Arginine; Binding Sites; Brain Neoplasms; Cell Division; Cell Line; Glioblastoma; Humans; Lysine; Mutagenesis, Site-Directed; Point Mutation; Rats; Receptor, IGF Type 1; Recombinant Proteins; Transfection; Tumor Cells, Cultured | 1995 |
Inhibition by lithium of cyclic GMP formation without inhibition of nitric oxide generation in the mouse neuroblastoma cell (N1E-115).
Topics: Animals; Arginine; Brain Neoplasms; Carbachol; Cyclic GMP; Guanylate Cyclase; Lithium; Mice; Muscarinic Antagonists; Neuroblastoma; Nitric Oxide; Nitroprusside; omega-N-Methylarginine; Tumor Cells, Cultured | 1994 |
Transport of L-arginine in cultured glial cells.
Topics: Amino Acids; Animals; Arginine; Astrocytes; Brain; Brain Neoplasms; Cells, Cultured; Glioma; Kinetics; Lipopolysaccharides; Mice; Neuroglia; Nitric Oxide; Potassium; Rats; Rats, Wistar; Tumor Cells, Cultured | 1994 |
Increased brain tumor microvessel permeability after intracarotid bradykinin infusion is mediated by nitric oxide.
Topics: Aminoisobutyric Acids; Animals; Arginine; Blood-Brain Barrier; Blotting, Western; Bradykinin; Brain Neoplasms; Capillary Permeability; Carbon Radioisotopes; Dextrans; Enzyme Inhibitors; Female; Glioma; Immunohistochemistry; Infusions, Intra-Arterial; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Rats; Rats, Wistar; Tumor Cells, Cultured | 1996 |
The impact of irradiation on growth hormone responsiveness to provocative agents is stimulus dependent: results in 161 individuals with radiation damage to the somatotropic axis.
Topics: Adult; Age Factors; Arginine; Brain Neoplasms; Child; Female; Human Growth Hormone; Humans; Hypopituitarism; Insulin; Male; Patient Selection; Puberty; Radioimmunoassay; Radiotherapy; Reference Values; Reproducibility of Results; Sensitivity and Specificity | 2001 |
Growth hormone response to a growth hormone-releasing hormone stimulation test in a population-based study following cranial irradiation of childhood brain tumors.
Topics: Adolescent; Arginine; Brain; Brain Neoplasms; Child; Child, Preschool; Female; Follow-Up Studies; Growth Hormone-Releasing Hormone; Human Growth Hormone; Humans; Hypothalamus; Infant; Male; Pituitary Gland; Radiation Injuries; Relative Biological Effectiveness; Time Factors | 2000 |
Evidence that CHP100 neuroblastoma cell death induced by N-methyl-D-aspartate involves L-arginine-nitric oxide pathway activation.
Topics: Amino Acid Oxidoreductases; Arginine; Biotransformation; Brain Neoplasms; Cell Death; Dizocilpine Maleate; Humans; N-Methylaspartate; Neuroblastoma; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Tumor Cells, Cultured | 1992 |
Effects of L-NMMA and L-NNA on the selective ATP-induced enhancement of intratumoral blood flow.
Topics: Adenosine; Adenosine Triphosphate; Animals; Arginine; Brain Neoplasms; Glioma; Male; Nitroarginine; omega-N-Methylarginine; Rats; Rats, Inbred Strains; Regional Blood Flow; Tumor Cells, Cultured | 1992 |
Polygraphic sleep patterns and growth hormone secretion in children after cranial irradiation.
Topics: Arginine; Brain; Brain Neoplasms; Child; Child, Preschool; Electroencephalography; Female; Growth Hormone; Humans; Infant; Insulin; Male; Sleep | 1991 |
The effects of cranial irradiation on growth hormone secretion.
Topics: Adolescent; Arginine; Brain; Brain Neoplasms; Child; Child, Preschool; Female; Follow-Up Studies; Growth Hormone; Humans; Hypothalamo-Hypophyseal System; Leukemia, Lymphoid; Male | 1986 |
Growth hormone responses to sleep, insulin hypoglycaemia and arginine infusion.
Topics: Adolescent; Arginine; Brain Neoplasms; Child; Female; Growth Disorders; Growth Hormone; Humans; Hypoglycemia; Injections, Intravenous; Insulin; Male; Radiotherapy; Sleep | 1985 |
Long-term effects of cranial irradiation on endocrine function in children with brain tumors. A prospective study.
Topics: Adolescent; Arginine; Brain; Brain Neoplasms; Child; Child, Preschool; Endocrine Glands; Female; Growth Disorders; Growth Hormone; Humans; Insulin; Male; Prospective Studies; Radiation Injuries | 1985 |
Hypothalamic gigantism.
Topics: Arginine; Brain Neoplasms; Child, Preschool; Chlorpromazine; Cobalt Isotopes; Dexamethasone; Gigantism; Glucose Tolerance Test; Growth Hormone; Humans; Hyperinsulinism; Hypothalamus; Insulin; Male; Neurofibromatosis 1; Pneumoencephalography | 1973 |
Growth hormone in marasmus die to cerebral disease.
Topics: Adolescent; Arginine; Astrocytoma; Birth Injuries; Blood Glucose; Brain Diseases; Brain Neoplasms; Celiac Disease; Child; Child, Preschool; Cystic Fibrosis; Dehydration; Depression, Chemical; Fatty Acids, Nonesterified; Female; Glucose; Growth Hormone; Humans; Hydrocephalus; Hypoglycemia; Hypoproteinemia; Infant; Insulin; Male; Nutrition Disorders; Radioimmunoassay; Stimulation, Chemical | 1973 |
Arginine content in serum protein and in serum protein fractions in cases of neoplastic disease.
Topics: Arginine; Blood Protein Electrophoresis; Brain Neoplasms; DNA; Esophageal Neoplasms; Female; Humans; Kidney Neoplasms; Liver Neoplasms; Lung Neoplasms; Middle Aged; Neoplasms; Serum Albumin; Serum Globulins; Uterine Neoplasms | 1971 |
Paradoxical growth in a patient with the diencephalic syndrome.
Topics: Arginine; Brain Neoplasms; Child; Child, Preschool; Diencephalon; Emaciation; Glioma; Glucose; Growth; Growth Disorders; Growth Hormone; Humans; Infant; Male; Metyrapone; Obesity; Optic Chiasm; Puberty, Precocious | 1970 |
Higher LRRFIP1 expression in glioblastoma multiforme is associated with better response to teniposide, a type II topoisomerase inhibitor.
Topics: Animals; Brain; Brain Neoplasms; Cell Line, Tumor; Gene Expression Regulation, Neoplastic; Glioblastoma; Humans; Mice; Mice, Nude; MicroRNAs; Prognosis; RNA-Binding Proteins; Teniposide; Topoisomerase II Inhibitors; Transfection; Up-Regulation | 2014 |
Carmustine (BCNU) plus Teniposide (VM26) in recurrent malignant glioma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carmustine; Disease-Free Survival; Female; Glioma; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Recurrence, Local; Retrospective Studies; Teniposide | 2014 |
Singapore Cancer Network (SCAN) Guidelines for Systemic Therapy of High-Grade Glioma.
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Bevacizumab; Brain Neoplasms; Camptothecin; Carboplatin; Chemoradiotherapy; Chemotherapy, Adjuvant; Chromosomes, Human, Pair 1; Chromosomes, Human, Pair 19; Cyclophosphamide; Dacarbazine; Glioblastoma; Humans; Irinotecan; Lomustine; Neoplasm Grading; Neoplasm Recurrence, Local; Oligodendroglioma; Procarbazine; Radiotherapy; Singapore; Temozolomide; Teniposide; Vincristine | 2015 |
Myoinositol as a Biomarker in Recurrent Glioblastoma Treated with Bevacizumab: A 1H-Magnetic Resonance Spectroscopy Study.
Topics: Adult; Aged; Angiogenesis Inhibitors; Antineoplastic Agents; Bevacizumab; Biomarkers, Tumor; Brain Neoplasms; Female; Glioblastoma; Humans; Hydrogen; Inositol; Lomustine; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Prospective Studies; Survival Analysis; Teniposide; Tumor Microenvironment; Vascular Endothelial Growth Factor A | 2016 |
Nimustine (ACNU) plus teniposide (VM26) in recurrent glioblastoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Female; Glioblastoma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Nimustine; Retrospective Studies; Teniposide | 2009 |
Adenovirus-mediated transfer of siRNA against basic fibroblast growth factor mRNA enhances the sensitivity of glioblastoma cells to chemotherapy.
Topics: Adenoviridae; Antineoplastic Agents; Apoptosis; Blotting, Western; Brain Neoplasms; Carmustine; Cell Movement; Cell Proliferation; Drug Resistance, Neoplasm; Fibroblast Growth Factor 2; Glioblastoma; Humans; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Small Interfering; Teniposide; Tumor Cells, Cultured | 2011 |
Study on the proliferation and drug-resistance of human brain tumor stem-like cells.
Topics: AC133 Antigen; Antigens, CD; Brain Neoplasms; Cell Death; Cell Differentiation; Cell Proliferation; Drug Resistance, Neoplasm; Flow Cytometry; Glioma; Glycoproteins; Humans; Neoplastic Stem Cells; Peptides; Spheroids, Cellular; Teniposide; Tumor Cells, Cultured | 2010 |
Decreasing expression of the interleukin-13 receptor IL-13Ralpha2 in treated recurrent malignant gliomas.
Topics: Actins; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Exotoxins; Female; Gene Expression Regulation, Neoplastic; Glioblastoma; Humans; Immunotoxins; Interleukin-13; Interleukin-13 Receptor alpha2 Subunit; Male; Middle Aged; Neoplasm Recurrence, Local; Nimustine; Recombinant Fusion Proteins; RNA; Teniposide; Young Adult | 2010 |
Knockdown of apoptosis repressor with caspase recruitment domain (ARC) increases the sensitivity of human glioma cell line U251MG to VM-26.
Topics: Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; bcl-2-Associated X Protein; Blotting, Western; Brain; Brain Neoplasms; Caspase 3; Caspase 8; Cell Line, Tumor; Cell Survival; Drug Screening Assays, Antitumor; Enzyme Activation; Gene Knockdown Techniques; Gene Silencing; Glioblastoma; Humans; Muscle Proteins; Teniposide | 2012 |
[A high performance liquid chromatographic method for the determination of teniposide in brain tissue using electro-chemical detection].
Topics: Brain Chemistry; Brain Neoplasms; Chromatography, High Pressure Liquid; Electrochemical Techniques; Humans; Teniposide | 1997 |
Hypofractionated stereotactic re-irradiation: treatment option in recurrent malignant glioma.
Topics: Antineoplastic Agents; Brain Neoplasms; Disease Progression; Dose Fractionation, Radiation; Dose-Response Relationship, Radiation; Glioblastoma; Glioma; Humans; Neoplasm Recurrence, Local; Nimustine; Prognosis; Radiosurgery; Radiotherapy; Recurrence; Stereotaxic Techniques; Teniposide; Time Factors; Treatment Outcome | 2005 |
Glioblastoma multiforme with oligodendroglial component (GBMO): favorable outcome after post-operative radiotherapy and chemotherapy with nimustine (ACNU) and teniposide (VM26).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Chemotherapy, Adjuvant; Combined Modality Therapy; Craniotomy; Disease Progression; Disease-Free Survival; Female; Glioblastoma; Humans; Life Tables; Male; Middle Aged; Nimustine; Oligodendroglia; Oligodendroglioma; Prognosis; Radiotherapy, Adjuvant; Survival Analysis; Teniposide; Treatment Outcome | 2006 |
Late results of multimodality therapy of high-grade supratentorial astrocytomas.
Topics: Adult; Antineoplastic Agents; Astrocytoma; Bleomycin; Brain Neoplasms; Drug Therapy, Combination; Female; Humans; Lomustine; Male; Middle Aged; Procarbazine; Teniposide | 1981 |
VM-26 monochemotherapy trial in the treatment of recurrent supratentorial gliomas: preliminary report.
Topics: Anemia; Astrocytoma; Brain Neoplasms; Chemical and Drug Induced Liver Injury; Female; Glioblastoma; Glioma; Humans; Kidney Diseases; Male; Neoplasm Recurrence, Local; Oligodendroglioma; Podophyllotoxin; Teniposide | 1981 |
Combination chemotherapy for metastatic brain tumors.
Topics: Adenocarcinoma; Brain Neoplasms; Breast Neoplasms; Carcinoma, Small Cell; Doxorubicin; Drug Therapy, Combination; Humans; Lomustine; Lung Neoplasms; Nitrosourea Compounds; Podophyllotoxin; Prognosis; Teniposide; Tomography, X-Ray Computed | 1981 |
[Antimitotic chemotherapy of supratentorial cerebral glioma in adults. Apropos of 56 cases].
Topics: Adult; Aged; Brain Neoplasms; Drug Therapy, Combination; Female; Glioma; Humans; Lomustine; Male; Middle Aged; Nitrosourea Compounds; Podophyllotoxin; Teniposide | 1983 |
[Prognostic value of gliofibrillary protein assay in malignant gliomas treated with chemo- and radiotherapy].
Topics: Adolescent; Adult; Brain Neoplasms; Drug Therapy, Combination; Female; Follow-Up Studies; Glial Fibrillary Acidic Protein; Glioma; Humans; Intermediate Filament Proteins; Lomustine; Male; Middle Aged; Prognosis; Teniposide | 1983 |
Penetration of teniposide (VM-26) into human intracerebral tumors. Preliminary observations on the effect of tumor type, rate of drug infusion and prior treatment with amphotericin B or oral glycerol.
Topics: Amphotericin B; Astrocytoma; Brain Neoplasms; Glycerol; Humans; Kinetics; Meningioma; Podophyllotoxin; Teniposide | 1984 |
[Second-look operations and chemotherapy for malignant tumors of the brain].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Child; Female; Glioma; Humans; Male; Middle Aged; Nimustine; Nitrosourea Compounds; Reoperation; Teniposide | 1983 |
[Synchronization chemoradiotherapy for malignant gliomas].
Topics: Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Combined Modality Therapy; Glioma; Humans; Nimustine; Nitrosourea Compounds; Teniposide; Vincristine | 1984 |
Etoposide (VP-16-213) in malignant brain tumors: a phase II study.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Drug Evaluation; Etoposide; Female; Glioma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Podophyllotoxin; Teniposide; Time Factors; Tomography, X-Ray Computed | 1984 |
Immune hemolytic anemia and renal failure due to teniposide.
Topics: Acute Kidney Injury; Anemia, Hemolytic, Autoimmune; Autoantibodies; Brain Neoplasms; Erythrocytes; Female; Humans; Kidney Tubular Necrosis, Acute; Male; Middle Aged; Podophyllotoxin; Teniposide | 1982 |
Combination chemotherapy with VM 26 and CCNU in primary malignant brain tumors of children.
Topics: Adolescent; Brain Neoplasms; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Lomustine; Male; Nitrosourea Compounds; Podophyllotoxin; Teniposide | 1980 |
The vascular compartment hampers accurate determination of teniposide penetration into brain tumor tissue.
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Brain; Brain Neoplasms; Breast Neoplasms; Capillary Permeability; Cerebrovascular Circulation; Female; Glioblastoma; Humans; Male; Melanoma; Middle Aged; Oligodendroglioma; Skin Neoplasms; Teniposide | 1997 |
Immunohistochemical expression of P-glycoprotein and glutathione S-transferases in cerebral gliomas and response to chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; ATP Binding Cassette Transporter, Subfamily B, Member 1; Brain Neoplasms; Drug Resistance, Neoplasm; Glioblastoma; Glutathione Transferase; Humans; Immunohistochemistry; Isoenzymes; Karnofsky Performance Status; Nimustine; Teniposide | 1997 |
Improved targeting of brain tumors using dexrazoxane rescue of topoisomerase II combined with supralethal doses of etoposide and teniposide.
Topics: Amsacrine; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Drug Administration Schedule; Etoposide; Female; Mice; Mice, Inbred Strains; Razoxane; Survival Rate; Teniposide; Topoisomerase II Inhibitors | 1998 |
Chemosensitivity of human malignant glioma: modulation by p53 gene transfer.
Topics: Amino Acid Substitution; Animals; Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Brain Neoplasms; Carmustine; Cell Division; Cytarabine; Doxorubicin; Drug Resistance, Neoplasm; Gene Deletion; Gene Expression Regulation, Neoplastic; Genes, bcl-2; Genes, p53; Glioma; Humans; Mice; Point Mutation; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Recombinant Fusion Proteins; Temperature; Teniposide; Transfection; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Vincristine | 1998 |
Accumulation of mutant p53(V143A) modulates the growth, clonogenicity, and radiochemosensitivity of malignant glioma cells independent of endogenous p53 status.
Topics: Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Brain Neoplasms; Camptothecin; Carmustine; Cell Death; Cell Division; Cisplatin; Clone Cells; Combined Modality Therapy; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Gene Expression Regulation, Neoplastic; Genes, Dominant; Glioma; Humans; In Vitro Techniques; Paclitaxel; Point Mutation; Radiotherapy; Teniposide; Topotecan; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Vincristine | 1999 |
Evidence for a constitutive, verapamil-sensitive, non-P-glycoprotein multidrug resistance phenotype in malignant glioma that is unaltered by radiochemotherapy in vivo.
Topics: Adolescent; Adult; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blood-Brain Barrier; Brain Neoplasms; Calcium Channel Blockers; Carmustine; Combined Modality Therapy; DNA, Neoplasm; Doxorubicin; Drug Resistance, Neoplasm; Female; Flow Cytometry; Gene Expression Regulation, Neoplastic; Glioblastoma; Humans; In Vitro Techniques; Male; Middle Aged; Phenotype; Reverse Transcriptase Polymerase Chain Reaction; Teniposide; Topotecan; Tumor Cells, Cultured; Verapamil; Vincristine | 2000 |
Distinct radiochemotherapy protocols differentially influence cellular proliferation and expression of p53 and Bcl-2 in glioblastoma multiforme relapses in vivo.
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Biomarkers; Brain Neoplasms; Cell Division; Chemotherapy, Adjuvant; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Cytarabine; Disease Progression; Female; Gene Expression Regulation, Neoplastic; Genes; Genes, bcl-2; Glioblastoma; GTP-Binding Proteins; Humans; Ki-67 Antigen; Life Tables; Lomustine; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplastic Stem Cells; Nimustine; Protein Glutamine gamma Glutamyltransferase 2; Proto-Oncogene Proteins c-bcl-2; Radiotherapy, Adjuvant; Survival Analysis; Teniposide; Transglutaminases; Tumor Suppressor Protein p53 | 2000 |
[Controversial treatment of brain metastases of small-cell lung cancer. Randomized comparison of chemotherapy alone and radiochemotherapy].
Topics: Antineoplastic Agents; Brain Neoplasms; Carcinoma, Small Cell; Chemotherapy, Adjuvant; Clinical Trials, Phase III as Topic; Humans; Lung Neoplasms; Neurologic Examination; Radiotherapy, Adjuvant; Randomized Controlled Trials as Topic; Teniposide; Treatment Outcome | 2001 |
[Palliative irradiation combined with chemotherapy for lung cancer with brain metastasis].
Topics: Adult; Aged; Antineoplastic Agents; Brain Neoplasms; Carcinoma, Non-Small-Cell Lung; Cisplatin; Female; Humans; Lung Neoplasms; Male; Middle Aged; Survival Rate; Teniposide; Treatment Outcome | 2001 |
[Enhanced cytotoxicity of VM-26 in human malignant glioma cells by calcium channel blocker nicardipine in vitro].
Topics: Antineoplastic Agents; Brain Neoplasms; Calcium Channel Blockers; Drug Synergism; Glioma; Humans; Nicardipine; Teniposide; Tumor Cells, Cultured | 1999 |
[Role of VM26 on glioma cells in vitro--analysis of G0 cells and recruitment (author's transl)].
Topics: Brain Neoplasms; Cells, Cultured; Glioma; Kinetics; Mitosis; Podophyllotoxin; Teniposide | 1978 |
[Treatment of inoperable glioblastomas using a combination of adriamycin, VM 26 and CCNU].
Topics: Adult; Aged; Brain Neoplasms; Doxorubicin; Drug Therapy, Combination; Drug Tolerance; Glioblastoma; Humans; Lomustine; Methods; Middle Aged; Nitrosourea Compounds; Podophyllotoxin; Teniposide | 1977 |
Cerebral pseudocysts following chemotherapy of glioblastomas.
Topics: Adult; Astrocytoma; Brain Diseases; Brain Neoplasms; Cysts; Glioblastoma; Humans; Lomustine; Male; Middle Aged; Teniposide; Tomography, X-Ray Computed | 1977 |
Sequential and adjuvant chemotherapy for malignant astrocytoma of the brain.
Topics: Brain Neoplasms; Carmustine; Drug Administration Schedule; Glioblastoma; Humans; Teniposide; Vomiting | 1978 |
[Value of chemotherapy associated with conventional treatment of malignant gliomas of the brain. Study of 95 cases with histological verification and follow-up of 1 to 6 years 9 months].
Topics: Administration, Oral; Adult; Brain Neoplasms; Carmustine; Drug Evaluation; Drug Therapy, Combination; Female; Follow-Up Studies; Glioblastoma; Glioma; Humans; Injections, Intravenous; Lomustine; Male; Middle Aged; Nitrosourea Compounds; Podophyllotoxin; Retrospective Studies; Teniposide | 1979 |
Preoperative radiotherapy and chemotherapy in hypervascular, high-grade supratentorial astrocytomas.
Topics: Adult; Aged; Brain Neoplasms; Drug Therapy, Combination; Female; Glioblastoma; Humans; Lomustine; Male; Middle Aged; Teniposide | 1979 |
Recruitment-chemoradiotherapy with VM 26 (epipodophyllotoxin) for induction treatment of malignant brain tumours.
Topics: Adenocarcinoma; Animals; Brain Neoplasms; Cell Line; Fibrosarcoma; Glioma; Humans; Mitosis; Neoplasm Metastasis; Neoplasm Transplantation; Neoplasms, Experimental; Podophyllotoxin; Radiotherapy Dosage; Rats; Teniposide; Vincristine | 1979 |
VM-26 as a second drug in the treatment of brain gliomas.
Topics: Antineoplastic Agents; Brain Neoplasms; Drug Therapy, Combination; Female; Glioma; Humans; Nitrosourea Compounds; Podophyllotoxin; Teniposide | 1979 |
Combination chemotherapy with VM 26 and CCNU in primary malignant brain tumors.
Topics: Adolescent; Adult; Aged; Brain Neoplasms; Child; Drug Therapy, Combination; Female; Humans; Lomustine; Male; Middle Aged; Neoplasm Recurrence, Local; Nitrosourea Compounds; Podophyllotoxin; Teniposide | 1979 |
Malignant gliomas treated after surgery by combination chemotherapy and delayed irradiation. Part I: Analysis of results.
Topics: Adolescent; Adult; Aged; Astrocytoma; Brain Neoplasms; Cobalt Radioisotopes; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Lomustine; Male; Middle Aged; Neoplasm Recurrence, Local; Nitrosourea Compounds; Podophyllotoxin; Radiotherapy Dosage; Teniposide | 1979 |
Malignant gliomas treated after surgery by combination chemotherapy and delayed radiation therapy. Part II. Tolerance to irradiation after chemotherapy.
Topics: Brain; Brain Neoplasms; Drug Therapy, Combination; Glioma; Humans; Lomustine; Neoplasm Recurrence, Local; Nitrosourea Compounds; Podophyllotoxin; Radiation Tolerance; Radiotherapy; Radiotherapy Dosage; Teniposide | 1979 |
Iv methyl-CCNU, VM-26, and cranial irradiation in therapy for malignant brain tumors.
Topics: Brain Neoplasms; Humans; Injections, Intravenous; Leukopenia; Nitrosourea Compounds; Podophyllotoxin; Semustine; Teniposide | 1977 |
Combined chemotherapy with VM 26 and BCNU for recurrent malignant gliomas after operation and irradiation.
Topics: Adult; Aged; Brain Neoplasms; Carmustine; Drug Therapy, Combination; Female; Glioma; Humans; Male; Middle Aged; Podophyllotoxin; Postoperative Period; Teniposide | 1978 |
[Neurogliale cerebral tumors: test of chemotherapy treatment. Forty five cases (author's transl)].
Topics: Adult; Aged; Brain Neoplasms; Child, Preschool; Drug Therapy, Combination; Echoencephalography; Electroencephalography; Female; Follow-Up Studies; Glioma; Humans; Immunity, Cellular; Lomustine; Male; Middle Aged; Radionuclide Imaging; Teniposide | 1978 |
Treatment of adult malignant gliomas.
Topics: Adult; Aged; Antineoplastic Agents; Brain Neoplasms; Drug Administration Schedule; Drug Therapy, Combination; Glioma; Humans; Lomustine; Middle Aged; Procarbazine; Teniposide | 1978 |
[Comparative in vitro action of various antimitotic agents on cell lines established from human brain neoplasms].
Topics: Antineoplastic Agents; Brain; Brain Neoplasms; Cell Division; Cell Line; Cells, Cultured; Embryo, Mammalian; Glioma; Humans; In Vitro Techniques; Meningioma; Teniposide | 1976 |
Treatment of malignant gliomas and brain metastases in adults with a combination of adriamycin, VM 26, and CCNU. Results of a phase II trail.
Topics: Adult; Aged; Brain Neoplasms; Doxorubicin; Drug Therapy, Combination; Drug Tolerance; Female; Glioma; Hematologic Diseases; Humans; Intracranial Pressure; Lomustine; Male; Middle Aged; Nausea; Neoplasm Metastasis; Nitrosourea Compounds; Podophyllotoxin; Teniposide; Vomiting | 1976 |
Treatment of brain metastases of small cell lung cancer with teniposide.
Topics: Aged; Aged, 80 and over; Brain Neoplasms; Carcinoma, Small Cell; Clinical Trials, Phase II as Topic; Female; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Remission Induction; Survival Rate; Teniposide; Thrombocytopenia | 1992 |
Induction of heat-shock response and alterations of protein phosphorylation by a novel topoisomerase II inhibitor, withangulatin A, in 9L rat brain tumor cells.
Topics: Animals; Brain Neoplasms; Cycloheximide; Dactinomycin; Heat-Shock Proteins; Hot Temperature; Kinetics; Phosphorylation; Pregnenes; Protein Biosynthesis; Proteins; Rats; Teniposide; Topoisomerase II Inhibitors; Tumor Cells, Cultured | 1991 |
Concentrations of VP16 and VM26 in human brain tumors.
Topics: Adult; Aged; Brain; Brain Neoplasms; Chromatography, High Pressure Liquid; Etoposide; Female; Humans; Male; Middle Aged; Teniposide; Tissue Distribution | 1991 |
[Chemotherapy in malignant gliomas].
Topics: Antineoplastic Agents; Brain Neoplasms; Carmustine; Combined Modality Therapy; Cytarabine; Follow-Up Studies; Glioma; Humans; Nimustine; Survival Rate; Teniposide | 1990 |
Vidarabin-monophosphate, BCNU, VM26--an in vitro comparative study of active agents in the treatment of malignant human brain tumours.
Topics: Adolescent; Aged; Arabinonucleotides; Brain Neoplasms; Carmustine; Cells, Cultured; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Female; Humans; Kinetics; Male; Middle Aged; Neoplastic Stem Cells; Podophyllotoxin; RNA, Neoplasm; Teniposide; Vidarabine Phosphate | 1987 |
Combined intraarterial and systemic chemotherapy for intracerebral tumors.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brain Neoplasms; Carmustine; Cisplatin; Glioma; Glycerol; Humans; Infusions, Intra-Arterial; Infusions, Intravenous; Methotrexate; Middle Aged; Procarbazine; Teniposide; Vincristine | 1987 |
Teniposide (VM26): an effective treatment for brain metastases of small cell carcinoma of the lung.
Topics: Aged; Brain Neoplasms; Carcinoma, Small Cell; Female; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Podophyllotoxin; Teniposide; Thrombocytopenia | 1988 |
Podophyllotoxins for brain metastases of small cell lung cancer.
Topics: Brain Neoplasms; Carcinoma, Small Cell; Etoposide; Humans; Lung Neoplasms; Male; Middle Aged; Podophyllotoxin; Teniposide | 1988 |
Application of in vivo and in vitro pharmacokinetics for physiologically relevant drug exposure in a human tumor clonogenic cell assay.
Topics: Antineoplastic Agents; Aziridines; Benzoquinones; Biological Assay; Brain Neoplasms; Carmustine; Cell Line; Cisplatin; Clone Cells; Dose-Response Relationship, Drug; Ellipticines; Glioma; Half-Life; Humans; Mathematics; Streptozocin; Teniposide | 1987 |
[Multimodal treatment of undifferentiated astrocytomas of the cerebrum. Indications for chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Combined Modality Therapy; Glioblastoma; Humans; Lomustine; Teniposide | 1985 |
In vitro chemosensitivity of brain tumors to cisplatin and its analogues, iproplatin and carboplatin.
Topics: Brain Neoplasms; Carboplatin; Carmustine; Cisplatin; Colony-Forming Units Assay; Drug Resistance; Humans; Mitolactol; Organoplatinum Compounds; Teniposide; Tumor Stem Cell Assay; Vindesine | 1988 |
[Abdominal metastasis of a pineal germinoma in a child with a ventriculo-peritoneal shunt].
Topics: Abdominal Neoplasms; Brain Neoplasms; Cerebrospinal Fluid Shunts; Child; Humans; Liver Neoplasms; Lomustine; Male; Pinealoma; Teniposide | 1987 |
Hypersensitivity reactions to teniposide (VM-26): an analysis.
Topics: Adolescent; Adult; Aged; Bibliographies as Topic; Blood Pressure; Brain Neoplasms; Child; Child, Preschool; Data Collection; Drug Evaluation; Drug Hypersensitivity; Edema; Humans; Hypersensitivity, Immediate; Infant; Leukemia; Male; Middle Aged; Neuroblastoma; Podophyllotoxin; Surveys and Questionnaires; Teniposide; Urticaria | 1986 |
Cytosine arabinoside plus cisplatin and other drugs as chemotherapy for gliomas.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Caffeine; Carmustine; Cisplatin; Cytarabine; Drug Synergism; Glioma; Humans; Teniposide | 1987 |